<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Biomolecules</journal-id>
<journal-id journal-id-type="iso-abbrev">Biomolecules</journal-id>
<journal-id journal-id-type="publisher-id">biomolecules</journal-id>
<journal-title-group>
<journal-title>Biomolecules</journal-title>
</journal-title-group>
<issn pub-type="epub">2218-273X</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32503154</article-id>
<article-id pub-id-type="pmc">7355890</article-id>
<article-id pub-id-type="doi">10.3390/biom10060848</article-id>
<article-id pub-id-type="publisher-id">biomolecules-10-00848</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cholinergic Stress Signals Accompany MicroRNA-Associated Stereotypic Behavior and Glutamatergic Neuromodulation in the Prefrontal Cortex</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Moshitzky</surname>
<given-names>Gilli</given-names>
</name>
<xref ref-type="aff" rid="af1-biomolecules-10-00848">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shoham</surname>
<given-names>Shai</given-names>
</name>
<xref ref-type="aff" rid="af2-biomolecules-10-00848">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8467-5085</contrib-id>
<name>
<surname>Madrer</surname>
<given-names>Nimrod</given-names>
</name>
<xref ref-type="aff" rid="af1-biomolecules-10-00848">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Husain</surname>
<given-names>Amir Mouhammed</given-names>
</name>
<xref ref-type="aff" rid="af1-biomolecules-10-00848">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Greenberg</surname>
<given-names>David S.</given-names>
</name>
<xref ref-type="aff" rid="af1-biomolecules-10-00848">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yirmiya</surname>
<given-names>Raz</given-names>
</name>
<xref ref-type="aff" rid="af3-biomolecules-10-00848">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ben-Shaul</surname>
<given-names>Yoram</given-names>
</name>
<xref ref-type="aff" rid="af4-biomolecules-10-00848">4</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0955-526X</contrib-id>
<name>
<surname>Soreq</surname>
<given-names>Hermona</given-names>
</name>
<xref ref-type="aff" rid="af1-biomolecules-10-00848">1</xref>
<xref ref-type="corresp" rid="c1-biomolecules-10-00848">*</xref>
</contrib>
</contrib-group>
<aff id="af1-biomolecules-10-00848"><label>1</label>The Institute of Life Sciences and The Edmond and Lily Safra Center of Brain Science, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel; <email>gilli.moshitzky@mail.huji.ac.il</email> (G.M.); <email>nm.isramail@gmail.com</email> (N.M.); <email>Amir.Husain@mail.huji.ac.il</email> (A.M.H.); <email>david.greenberg1@mail.huji.ac.il</email> (D.S.G.)</aff>
<aff id="af2-biomolecules-10-00848"><label>2</label>Herzog Medical Center, Givat Shaul, P.O. Box 3900, Jerusalem 9103702, Israel; <email>shaisho.shoham09@gmail.com</email></aff>
<aff id="af3-biomolecules-10-00848"><label>3</label>Department of Psychology, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel; <email>raz.yirmiya@mail.huji.ac.il</email></aff>
<aff id="af4-biomolecules-10-00848"><label>4</label>Department of Medical Neurobiology, The Institute of Medical Research Israel-Canada, Jerusalem 9112102, Israel; <email>yoramb@ekmd.huji.ac.il</email></aff>
<author-notes>
<corresp id="c1-biomolecules-10-00848"><label>*</label>Correspondence: <email>hermona.soreq@mail.huji.ac.il</email>; Tel.: +972-2-658-5109</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>03</day>
<month>6</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<month>6</month>
<year>2020</year>
</pub-date>
<volume>10</volume>
<issue>6</issue>
<elocation-id>848</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>5</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>5</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© 2020 by the authors.</copyright-statement>
<copyright-year>2020</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Stereotypic behavior (SB) is common in emotional stress-involved psychiatric disorders and is often attributed to glutamatergic impairments, but the underlying molecular mechanisms are unknown. Given the neuro-modulatory role of acetylcholine, we sought behavioral-transcriptomic links in SB using TgR transgenic mice with impaired cholinergic transmission due to over-expression of the stress-inducible soluble ‘readthrough’ acetylcholinesterase-R splice variant AChE-R. TgR mice showed impaired organization of behavior, performance errors in a serial maze test, escape-like locomotion, intensified reaction to pilocarpine and reduced rearing in unfamiliar situations. Small-RNA sequencing revealed 36 differentially expressed (DE) microRNAs in TgR mice hippocampi, 8 of which target more than 5 cholinergic transcripts. Moreover, compared to FVB/N mice, TgR prefrontal cortices displayed individually variable changes in over 400 DE mRNA transcripts, primarily acetylcholine and glutamate-related. Furthermore, TgR brains presented c-fos over-expression in motor behavior-regulating brain regions and immune-labeled AChE-R excess in the basal ganglia, limbic brain nuclei and the brain stem, indicating a link with the observed behavioral phenotypes. Our findings demonstrate association of stress-induced SB to previously unknown microRNA-mediated perturbations of cholinergic/glutamatergic networks and underscore new therapeutic strategies for correcting stereotypic behaviors.</p>
</abstract>
<kwd-group>
<kwd>acetylcholinesterase</kwd>
<kwd>cholinergic</kwd>
<kwd>glutamatergic</kwd>
<kwd>hippocampus</kwd>
<kwd>prefrontal cortex</kwd>
<kwd>microRNAs</kwd>
<kwd>motor control</kwd>
<kwd>stereotypic behavior</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-biomolecules-10-00848" sec-type="intro">
<title>1. Introduction</title>
<p>Stereotypic behavior (SB) involves patterned, repetitive, apparently purposeless movements [<xref ref-type="bibr" rid="B1-biomolecules-10-00848">1</xref>]. SB occurs in patients with Tourette’s syndrome and obsessive-compulsive disorder [<xref ref-type="bibr" rid="B2-biomolecules-10-00848">2</xref>], schizophrenia [<xref ref-type="bibr" rid="B3-biomolecules-10-00848">3</xref>], autism [<xref ref-type="bibr" rid="B4-biomolecules-10-00848">4</xref>,<xref ref-type="bibr" rid="B5-biomolecules-10-00848">5</xref>], oculo-cerebro-renal disorder of Lowe (OCRL) [<xref ref-type="bibr" rid="B6-biomolecules-10-00848">6</xref>], fragile X syndrome [<xref ref-type="bibr" rid="B7-biomolecules-10-00848">7</xref>], Rett’s syndrome [<xref ref-type="bibr" rid="B8-biomolecules-10-00848">8</xref>] and the stereotypic movement disorder in children [<xref ref-type="bibr" rid="B9-biomolecules-10-00848">9</xref>]. The underlying mechanism(s) are largely unknown, but impaired emotional stress modulation is likely involved, particularly in Tourette’s syndrome [<xref ref-type="bibr" rid="B10-biomolecules-10-00848">10</xref>,<xref ref-type="bibr" rid="B11-biomolecules-10-00848">11</xref>]. Tourette’s patients display enhanced frequency and intensity of stereotypic motor patterns (tics) under threatening situations [<xref ref-type="bibr" rid="B12-biomolecules-10-00848">12</xref>,<xref ref-type="bibr" rid="B13-biomolecules-10-00848">13</xref>], and children show increased SB in unfamiliar settings [<xref ref-type="bibr" rid="B1-biomolecules-10-00848">1</xref>]. The variability among human Tourette patients precludes a thorough exploration of the underlying mechanism(s), underlining the need for animal models of this syndrome.</p>
<p>Approaches employing pharmacological induction suggest a major role for glutamatergic neurotransmission in SB [<xref ref-type="bibr" rid="B14-biomolecules-10-00848">14</xref>,<xref ref-type="bibr" rid="B15-biomolecules-10-00848">15</xref>,<xref ref-type="bibr" rid="B16-biomolecules-10-00848">16</xref>], but they also affect the motor and stress-induced variables. In caged animals, both stimulus-poor environments and cage mate aggression have been implicated as causes for neurodevelopmental changes that lead to behavioral stereotypies [<xref ref-type="bibr" rid="B17-biomolecules-10-00848">17</xref>]. A related hypothesis views SB as a coping behavior elicited to relieve captivity stress [<xref ref-type="bibr" rid="B18-biomolecules-10-00848">18</xref>]. However, this hypothesis is inconsistent with the findings that neither chronic administration of corticotrophin releasing factor (CRF) nor transgenic overexpression of glucocorticoid receptors [<xref ref-type="bibr" rid="B19-biomolecules-10-00848">19</xref>] induce SB, and why avoiding SB failed to modify hormone levels in the hypothalamic-pituitary axis [<xref ref-type="bibr" rid="B20-biomolecules-10-00848">20</xref>]. Others proposed that SB reflects disorganized function in executive brain regions, and correlated cage-observed stereotypic behavior patterns (frequently exhibited by captive animals) with impaired maze performance [<xref ref-type="bibr" rid="B17-biomolecules-10-00848">17</xref>]. Compatible with this hypothesis, Tourette’s and autism subjects with more severe mental retardation show higher prevalence of SB [<xref ref-type="bibr" rid="B5-biomolecules-10-00848">5</xref>,<xref ref-type="bibr" rid="B21-biomolecules-10-00848">21</xref>,<xref ref-type="bibr" rid="B22-biomolecules-10-00848">22</xref>]. However, thus far, brains of caged animals revealed very few alterations which could indicate the molecular mechanisms underlying SB. The importance of this phenomenon, combined with the limited knowhow on its underlying processes initiated our interest in pursuing transcriptomic tools for seeking the neurotransmission processes involved in SB via a bottom-up approach.</p>
<p>Stress effects on higher brain functions involve neuronal activation of several neurotransmitter systems, including glutamate [<xref ref-type="bibr" rid="B23-biomolecules-10-00848">23</xref>], dopamine [<xref ref-type="bibr" rid="B24-biomolecules-10-00848">24</xref>] and neuromodulation of both by acetylcholine (ACh) [<xref ref-type="bibr" rid="B25-biomolecules-10-00848">25</xref>,<xref ref-type="bibr" rid="B26-biomolecules-10-00848">26</xref>,<xref ref-type="bibr" rid="B27-biomolecules-10-00848">27</xref>,<xref ref-type="bibr" rid="B28-biomolecules-10-00848">28</xref>,<xref ref-type="bibr" rid="B29-biomolecules-10-00848">29</xref>,<xref ref-type="bibr" rid="B30-biomolecules-10-00848">30</xref>,<xref ref-type="bibr" rid="B31-biomolecules-10-00848">31</xref>,<xref ref-type="bibr" rid="B32-biomolecules-10-00848">32</xref>,<xref ref-type="bibr" rid="B33-biomolecules-10-00848">33</xref>,<xref ref-type="bibr" rid="B34-biomolecules-10-00848">34</xref>]. However, although SB is readily induced by dopamine agonists, and is modulated by stressful experiences [<xref ref-type="bibr" rid="B35-biomolecules-10-00848">35</xref>,<xref ref-type="bibr" rid="B36-biomolecules-10-00848">36</xref>], neither psychiatric patients nor animals with cage stereotypies showed excessive dopaminergic neurotransmission. These findings directed our attention to the putative links between glutamate and ACh in SB, possibly via regulatory microRNAs (miRNAs).</p>
<p>MiRNAs are non-coding RNAs, shown to be involved in the regulation of protein expression but whose role in SB remains unclear. MiRNA stem-and-loop molecules are generated from primary transcripts that are cleaved to yield 22–25 bp mature double-stranded forms, one of which guides the complex to a partially complementary sequence often found in the 3′-untranslated region (3′-UTR) region of target genes [<xref ref-type="bibr" rid="B35-biomolecules-10-00848">35</xref>,<xref ref-type="bibr" rid="B37-biomolecules-10-00848">37</xref>]. The miRNA 5′-end ‘seed’ region dictates target specificity and determines whether the mRNA will be translationally repressed and if it will be cleaved. Promiscuous complementation enables one miRNA to target more than one mRNA and achieve gene-network-level regulation, and genes in specific networks share common themes that could enable targeting by a single miRNA [<xref ref-type="bibr" rid="B36-biomolecules-10-00848">36</xref>]. In the central nervous system, miRNAs are involved in diverse functions including neuronal development, plasticity and cellular function. Many brain miRNAs have been found to be changed in behavioral mouse models [<xref ref-type="bibr" rid="B38-biomolecules-10-00848">38</xref>,<xref ref-type="bibr" rid="B39-biomolecules-10-00848">39</xref>,<xref ref-type="bibr" rid="B40-biomolecules-10-00848">40</xref>], but the impact of miRNAs on SB pathogenesis is still not understood. Specifically, each miRNA may target a number of different mRNA sequences; therefore, the identification of target sequences acted on by the identified mis-regulated miRNAs has not yet been well defined. </p>
<p>Identifying the neurotransmission pathways involved in SB is also challenging, as receptors for the stress-response organizing agent CRF are present on glutamatergic, dopaminergic, serotonergic, noradrenergic and cholinergic neurons, indicating complex neuro-modulatory processes. Specifically, intraventricular CRF administration increases ACh release from cholinergic terminals in several forebrain regions controlling motor behavior [<xref ref-type="bibr" rid="B26-biomolecules-10-00848">26</xref>], thereby potentiating principal neuron reactions to incoming messages via nicotinic receptor activation [<xref ref-type="bibr" rid="B25-biomolecules-10-00848">25</xref>]. This indicates that cholinergic signals and their modification by miRNA regulators may upregulate motor functions under stress. Supporting this notion, cholinergic neurotransmission can modulate several levels of the hierarchy of motor behavior. Notably, this often occurs in an opposing manner to glutamatergic signaling [<xref ref-type="bibr" rid="B27-biomolecules-10-00848">27</xref>,<xref ref-type="bibr" rid="B31-biomolecules-10-00848">31</xref>,<xref ref-type="bibr" rid="B32-biomolecules-10-00848">32</xref>]. Based on this knowhow, our working hypothesis predicted that stress could promote SB by modulating the regulation of motor behavior via exchanging glutamatergic with cholinergic signaling. To test this prediction, we examined transgenic mice with enforced decline in cholinergic signaling for both SB and brain transcriptomic changes of short (seeking modified miRNAs) and long transcripts (pursuing changes in their mRNA targets). </p>
<p>Our mouse model involved elevated expression levels of acetylcholinesterase (AChE), known to occur under stress [<xref ref-type="bibr" rid="B33-biomolecules-10-00848">33</xref>]. This overexpression could be the effect of moderating excitatory influences on stress responses and involves alternative splicing, changing AChE properties [<xref ref-type="bibr" rid="B28-biomolecules-10-00848">28</xref>,<xref ref-type="bibr" rid="B29-biomolecules-10-00848">29</xref>,<xref ref-type="bibr" rid="B34-biomolecules-10-00848">34</xref>]. The normally rare, soluble variant AChE-R is induced by stress via alternative splicing of AChE pre-mRNA and is a preferred target of the stress-induced miRNA-132 [<xref ref-type="bibr" rid="B30-biomolecules-10-00848">30</xref>] and miRNA-125b [<xref ref-type="bibr" rid="B41-biomolecules-10-00848">41</xref>]. Therefore, we hypothesized that long-term AChE-R over-expression could elicit stress-related stereotypic motor behavior, by acting on neural mechanisms leading to SB. We further predicted that these could encompass various brain regions which control defensive motor responses, including the basal ganglia, limbic brain nuclei [<xref ref-type="bibr" rid="B42-biomolecules-10-00848">42</xref>,<xref ref-type="bibr" rid="B43-biomolecules-10-00848">43</xref>,<xref ref-type="bibr" rid="B44-biomolecules-10-00848">44</xref>,<xref ref-type="bibr" rid="B45-biomolecules-10-00848">45</xref>] and brainstem regions [<xref ref-type="bibr" rid="B46-biomolecules-10-00848">46</xref>]; and that this might involve marked changes in miRNAs targeted at cholinergic genes. </p>
<p>We set out to test the association of modifications in cholinergic-targeting miRNAs in SB by focusing on transgenic TgR mice overexpressing the human (h)AChE-R constitutively, under the minimal promoter-enhancer of cytomegalovirus (CMV). At the behavioral level, we tested TgR mice for spontaneous SB and reaction to the muscarinic stimulator pilocarpine. At the molecular level, we performed short RNA-sequencing and mRNA transcriptomic analysis of brain tissues from TgR mice, seeking modified cholinergic transcripts and their targeting miRNAs. CMV-directed gene expression depends on neuronal activity and blocks the neuro-inflammatory NFkB response regulated by cholinergic signaling [<xref ref-type="bibr" rid="B47-biomolecules-10-00848">47</xref>]. Therefore, we further examined the neuronal distribution and intensity of hAChE-R overexpression and assessed neuronal activity levels by labeling the immediate early gene c-fos, shown to associate both with SB-related neural activation [<xref ref-type="bibr" rid="B16-biomolecules-10-00848">16</xref>] and with AChE-R over-production [<xref ref-type="bibr" rid="B28-biomolecules-10-00848">28</xref>].</p>
</sec>
<sec id="sec2-biomolecules-10-00848">
<title>2. Materials and Methods</title>
<p><italic>Animals:</italic> Control, FVB/N and TgR transgenic mice were housed in the animal colony of the Herzog hospital, with an ambient temperature of 21 ± 2 °C and with a 12:12 h light: dark cycle. Experimental procedures were approved by the ethical committee MD98.08-2 of The Hebrew University of Jerusalem.</p>
<sec id="sec2dot1-biomolecules-10-00848">
<title>2.1. Behavioural Tests</title>
<p><italic>Measurements of open field motor activity:</italic> Spontaneous stereotypic behavior in an open field was followed from weaning (3–4 weeks of age) to adulthood (2–12 months of age). Following 30 min habituation in a holding cage, mice were placed for 5 min at the mildly stressful, brightly lit, center of a 40 × 40 cm open field with 20 cm high walls. Videotaped locomotor activity was first quantified as total time spent in locomotion. Rearing episodes were quantified to evaluate the extent of disruption of normal exploration under SB. Episodes in which the mouse-initiated locomotion (“locomotion events”) were counted. An index of asymmetry was calculated as [(left turns − half the total events)/total events] * 100. Thus, perfect symmetry would yield a value of 0 and total asymmetry—50%. For measurement of circadian motor activity, see <xref ref-type="app" rid="app1-biomolecules-10-00848">Supplementary Material, Supplementary Figure S1</xref>.</p>
<p><italic>Neurological tests:</italic> Mice were examined at the peak of their motor activity during the dark phase. Deficits in vestibular function were tested by holding mice by the tail, lifting and then lowering them over a metal cage top. Then, while the mouse was still, tactile stimuli to the right or left shoulder and trunk were applied using a cotton swab, and orienting to the stimulus was noted. Efficient and symmetric head and limb placement, and symmetric head orienting to tactile stimuli were taken as evidence of normal vestibular functioning.</p>
<p><italic>Assessment of context-dependent SB:</italic> Mice were observed in a brightly lit open field on test day 1, 20 min after saline injection, returned to a holding cage for 20 min and re-observed in a dimly lit room while in their home-cage. On test day 2, mice were observed in the same sequence described above, 20 min after injection. </p>
<p><italic>Forced swimming:</italic> Mice were placed in a circular water container, 20 × 20 cm in diameter and depth. Following a 4 min swim, at 25 °C, mice were taken out of the water and dried under a warm lamp. Total time spent swimming, number of swim episodes adjacent to the wall, number of swims across the container; number of circles and % asymmetry in the direction of swimming calculated by the index of asymmetry (see above) were quantified from video records.</p>
<p><italic>Two unit serial maze:</italic> Modular units placed in a series constitute this maze (85). To complete one “run”, a 22 h water-deprived mouse must choose between turning right or left to receive, at the end of the maze, a reward in the form of 40 μL of 5% sucrose and one “run” is considered complete. Then the mouse must shuttle back to the other end of the maze where it gets the same reward. There were 5 runs per session; one session per day. Quantitative measures of performance include numbers of left/right choice errors, “retrace errors”—episodes in which a mouse moves in the wrong direction (toward the end without a reward), time to complete a session (5 rewarded runs) and number of errorless runs per session (5 errorless runs is the highest performance level). </p>
</sec>
<sec id="sec2dot2-biomolecules-10-00848">
<title>2.2. Histology and Immunolabeling</title>
<p>Mice were euthanized 80–90 min after behavioral experiments by an intraperitoneal injection of 200 mg/kg sodium pentobarbital (“Pental”). Brains were fixed by trans-cardial perfusion with ice-cold 4% paraformaldehyde containing 4% sucrose (pH = 7.4). For cellular tests we labeled ARP, the C-terminal peptide unique for AChE-R, using a rabbit polyclonal antibody [<xref ref-type="bibr" rid="B48-biomolecules-10-00848">48</xref>]. Cholinergic neurons were identified by goat anti-choline-acetyltransferase (Chemicon, Temecula, USA). General AChE was labeled with goat anti-AChE (Santa Cruz, CA, USA, antibody N19). In co-localization studies, we used secondary antibodies: fluorescein (FITC)-labeled donkey anti-rabbit to visualize hAChE-R, donkey anti-goat for choline-acetyltransferase, and streptavidin-Cy3 to visualize general AChE. hAChE-R accumulating neurons were counted in hippocampal sub-regions CA1-2 (for brevity, hereafter referred to as CA1), CA3, and dentate gyrus (DG). In addition, hAChE-R accumulating neurons were counted in the striatum (in sampled rectangular fields measuring 420 × 680 µm) and in the red nucleus and the hypothalamus. Two to three coronal brain sections were sampled at an estimated distance of 2.8–3.3 mm posterior to bregma. Images of each hippocampal sub-region were acquired and analyzed using the AnalySIS software (SIS, Germany). In situ hybridization was essentially as described [<xref ref-type="bibr" rid="B48-biomolecules-10-00848">48</xref>].</p>
</sec>
<sec id="sec2dot3-biomolecules-10-00848">
<title>2.3. Measurements of Open Field Motor Activity</title>
<p>At the age of 5 weeks, all TgR mice displayed motor activity comparable to parent strain FVB/N mice, yet by 17 weeks, they segregated into two subpopulations. About 40% of transgenics (designated TgR-L) display locomotor activity comparable to that of FVB/N controls, whereas 60% express locomotor hyperactivity (TgR-H; <xref ref-type="table" rid="biomolecules-10-00848-t001">Table 1</xref>). The hyperactivity of TgR-H mice was manifested as locomotor asymmetry which frequently developed into stereotypic circling (<xref ref-type="fig" rid="biomolecules-10-00848-f001">Figure 1</xref>A,B), and repeating locomotor paths whereas both FVB/N and TgR-L mice readily explored and engaged in a variable succession of movements. Oral stereotypy (e.g., chewing, biting or licking) was not evident in TgR-H mice. Rearing, grooming, and the stretch-attend posture, all of which are normal components of exploratory behavior, were rare. Unlike TgR-H mice, TgR-L mice were similar to FVB/N control mice in all features (<xref ref-type="table" rid="biomolecules-10-00848-t001">Table 1</xref>A and <xref ref-type="app" rid="app1-biomolecules-10-00848">Supplementary Figure S1A–D</xref>). When testing behavior, we referred to the individual differences in the behavioral patterns of individual mice as significant and relevant, and separated mice into TgR-L and TgR-H as detailed below.</p>
<p>When the mice were single-housed in cages containing a running wheel, TgR-H mice engaged in SB at the expense of wheel running and ran the wheel considerably less than did FVB/N control mice (daily means of 2455 ± 1350 as compared to 7370 ± 1570 counts, <italic>t</italic>-test (df = 10) = 2.4, <italic>p</italic> &lt; 0.04). Thus, SB is not due only to an increased motor drive, which could be vented by use of the running wheel. Nevertheless, the circadian locomotion cycle was essentially normal except that TgR-H mice displayed higher activity during the first half of the dark phase (<xref ref-type="app" rid="app1-biomolecules-10-00848">Supplementary Figure S1E,F</xref>). </p>
<p>Spontaneous stereotypic behavior (SB) in an open field was sought from weaning (3–4 weeks of age) to adulthood (2–12 months of age). Following 30 min of habituation in a holding cage, mice were placed for 5 min at the mildly stressful, brightly lit, center of a 40 × 40 cm open field with 20 cm high walls. Videotaped locomotor activity was first quantified as total time spent in locomotion. Rearing episodes were quantified to evaluate the extent of disruption of normal exploration under SB. Episodes in which the mouse has initiated locomotion (“locomotion events”) were counted. An index of asymmetry was calculated as: left turns—half the total events/total events *100. Thus, perfect symmetry would yield a value of 0 and total asymmetry—50%. </p>
</sec>
<sec id="sec2dot4-biomolecules-10-00848">
<title>2.4. Telemetric Measurement of Motor Activity</title>
<p>Telemetric activity measurements were performed as detailed previously [<xref ref-type="bibr" rid="B49-biomolecules-10-00848">49</xref>], following intraperitoneal (ip) injection of ketamine–xylazine mixture (4.25, 0.15 mg/mouse) as anesthesia for transmitters implantation. Recordings lasted for 48 consecutive h starting at 7 am (beginning of light phase).</p>
</sec>
<sec id="sec2dot5-biomolecules-10-00848">
<title>2.5. Vestibular Test</title>
<p>Mice were examined at the peak of their motor activity during the dark phase. Deficits in vestibular function were tested by holding mice by the tail, lifting and then lowering them over a metal cage top. Then, while the mouse was still, a tactile stimulus to the right or left shoulder and trunk was applied using a cotton swab, and orienting to the stimulus was noted. Efficient and symmetric head and limb placement, and symmetric head orienting to tactile stimuli were considered as evidence for normal vestibular functioning. </p>
</sec>
<sec id="sec2dot6-biomolecules-10-00848">
<title>2.6. Forced Swimming</title>
<p>The TgR-H phenotype extended to situations involving motor behaviors other than locomotion. Thus, in a forced swim test, TgR-H, but not TgR-L, mice swam along the wall significantly more than FVB/N mice, which tended to sample alternative routes (e.g., swimming across the container). TgR-H mice further displayed a rigid pattern of swimming direction and circling asymmetry, to the same direction as in the open field (<xref ref-type="fig" rid="biomolecules-10-00848-f001">Figure 1</xref>B). Mice were placed in a circular water container, 20 × 20 cm in diameter and depth. Following a 4 min swim at 25 °C, mice were taken out of the water and dried under a warm lamp. Total time spent swimming, number of swim episodes adjacent to the wall, number of swims across the container, number of circles and % asymmetry in the direction of swimming (calculated by the index of asymmetry) were quantified from video records. SB in this test was reflected by motor hyperactivity, reduced exploratory behavior and motor asymmetry.</p>
</sec>
<sec id="sec2dot7-biomolecules-10-00848">
<title>2.7. Small RNA-Sequencing</title>
<p>In principle, we expected global changes in gene expression to primarily depend on the genomic composition of the tested mice. Therefore, we have used brain tissues from all of the TgR transgenics as compared to the control (wild type) mice from the same strain for the molecular analyses (microarray tests, RT-qPCR measurements and analyses thereof). Briefly, total RNA was extracted from murine brain tissues using the miRNeasy Mini Kit (Qiagen, 217004, Venlo, The Netherlands). Four TgR and three FVB/N mice were used for the prefrontal cortex (PFC) analyses, and three TgR and three FVB/N mice were used for the hippocampal preparations. RNA quality and quantity were measured using a Nanodrop 2000 (PeqLab/Thermo Scientific, Waltham, MA, USA). RNA integrity was tested using the 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA) RNA 6000 Nano LabChip Kits (Agilent Technologies) which revealed a RIN values range of 8.6–9.3. 300ng of RNA were subjected to small-RNA sequencing. Libraries were generated using an RNA Library prep kit (NEBNext E7300 Multiplex Small RNA Library Prep Set for Illumina, Foster City, CA, USA) following manufacturer’s instructions. Libraries were barcoded and sequenced on a NextSeq Series Sequencing System (HUJI Center for Genomic Technologies, Jerusalem, Israel) using an Illumina flow cell (Illumina 500 NextSeq High Output v2 Kit, FC-404-2005; Illumina). Quality control was performed using FastQC [<xref ref-type="bibr" rid="B50-biomolecules-10-00848">50</xref>], version 0.11.8. Short RNA was aligned to the miRBase version 21 using miRExpress2.0 [<xref ref-type="bibr" rid="B51-biomolecules-10-00848">51</xref>] with default parameters. Expression analysis was performed using the Bioconductor DESeq2 [<xref ref-type="bibr" rid="B52-biomolecules-10-00848">52</xref>] software via R platform [<xref ref-type="bibr" rid="B53-biomolecules-10-00848">53</xref>].</p>
</sec>
<sec id="sec2dot8-biomolecules-10-00848">
<title>2.8. Transcriptomic Analysis</title>
<p>Prefrontal cortices (PFCs) and Striatal Caudate-Putamen regions (CP) from groups of four FVB/N (wt) and four TgR animals were dissected on ice. Total PFC and CP RNA was extracted using the RNeasy mini kit (Qiagen, Hulden, Germany). Transcriptome profiles of two independent pools of PFC and CP RNAs from male age and strain-matched FVB/N and TgR mice (3–4 animals in each pool) were each hybridized to four standard Affymetrix mouse arrays (MgU74Av2) with 12,450 different transcripts for a total of 4 microarrays. Microarrays were used as per manufacturer’s instructions and the MIAME (<uri xlink:href="www.mged.org">www.mged.org</uri>) instructions. Analysis involved fluidic station FS-400, MAS 5.0 software and GeneArray 2500 scanner (Affymetrix). Transcripts were designated as absent or present according to the Affymterix manual where marginal (M) detection levels were counted as absent. A transcript was designated as changed if there was a robust change according to the Affymetrix manual (in the same direction) for at least 3 out of 4 comparisons (2 × 2 pools from each treatment). Data mining and graphs were carried out using the Spotfire program (Spotfire, Sommerville, MA, USA) and Excel. To identify the over-represented categories among those that were changed in the TgR brain, we performed Gene Ontologies (GO) classification using the freely available online GOstat tool [<xref ref-type="bibr" rid="B54-biomolecules-10-00848">54</xref>]. </p>
</sec>
<sec id="sec2dot9-biomolecules-10-00848">
<title>2.9. Quantitative PCR (qPCR)</title>
<p>cDNA was prepared using the Quanta qScript mRNA cDNA Synthesis Kit (Quantabio, Beverly, MA, USA) according to the manufacturer’s instructions and diluted 1:10 in double-distilled water prior to qPCR plate preparation. qPCR was performed in either 384-well or 96-well plates on CFX-384/96 machines (Bio-Rad), using Perfecta Sybr Green FastMix with low or No Rox (Quantabio) at a final well volume of 5 or 15 μL, respectively. β-actin and RPL-19 were used as housekeeping genes. Expression was calculated as ΔΔCt values using the Bio-Rad CFX Maestro 1.1 Software Version 4.1.2433.1219. </p>
</sec>
<sec id="sec2dot10-biomolecules-10-00848">
<title>2.10. Statistical Analyses</title>
<p>Histological data was subjected to ANOVA with a simple between-groups design comparing wild type FVB/N and TgR mice. Behavioral data, which included multiple tests conducted on each mouse, was analyzed using one-way ANOVA with repeated measures within each group (FVB/N and TgR) and between groups (FVB/N vs. TgR). Other statistical tests are noted where relevant. </p>
</sec>
</sec>
<sec id="sec3-biomolecules-10-00848" sec-type="results">
<title>3. Results</title>
<sec id="sec3dot1-biomolecules-10-00848">
<title>3.1. TgR Mice Show Clear SB Characteristics</title>
<p>At the age of 17 and 30 weeks, TgR mice displayed exacerbated motor activity compared to age-matched FVB/N controls. Although there were relatively high individual behavioral differences among TgR as compared to FVB/N mice (<xref ref-type="table" rid="biomolecules-10-00848-t002">Table 2</xref> and <xref ref-type="table" rid="biomolecules-10-00848-t003">Table 3</xref> and <xref ref-type="app" rid="app1-biomolecules-10-00848">Supplementary Figure S1</xref>), most TgR mice exhibited symptoms that are indicative of SB, including motor hyperactivity, which was evident both in the forced swim (<xref ref-type="fig" rid="biomolecules-10-00848-f001">Figure 1</xref>A and <xref ref-type="app" rid="app1-biomolecules-10-00848">Supplementary Movie</xref> S1) and the open-field (<xref ref-type="fig" rid="biomolecules-10-00848-f001">Figure 1</xref>B) paradigms, and was also observed under continuous automated telemetric recording. Moreover, TgR mice presented stereotypic and rigid behavioral patterns which accompanied their less than normal exploratory behaviors as observed in matched controls. For example, TgR mice exhibited stereotypic circling and swimming along the wall under forced swim stress, unlike FVB/N mice which tended to sample alternative routes (e.g., swimming across the container) (<xref ref-type="fig" rid="biomolecules-10-00848-f001">Figure 1</xref>A). In the open-field test, TgR mice presented locomotor hyperactivity at the expense of normal exploratory behaviors, reflected by marked decline in rearing. They also showed less grooming and stretch-attend postures, which are normal components of exploratory behavior (<xref ref-type="fig" rid="biomolecules-10-00848-f001">Figure 1</xref>B–D). </p>
<p>Interestingly, when TgR mice were single-housed in cages containing a running wheel, they engaged in SB and ran the wheel considerably less than the FVB/N control mice (daily means of 2455 ± 1350 as compared to 7370 ± 1570 counts, <italic>t</italic>-test (df = 10) = 2.4, <italic>p</italic> &lt; 0.04). Thus, the abnormal locomotion patterns were unlikely to be due to an increased motor drive, which could be vented by use of the running wheel. Additionally, TgR mice exhibited motor asymmetry, both in the forced swim (<xref ref-type="fig" rid="biomolecules-10-00848-f001">Figure 1</xref>A) and the open-field (<xref ref-type="fig" rid="biomolecules-10-00848-f001">Figure 1</xref>E) tests, where they displayed circling or locomotion asymmetry, turning to the same direction repeatedly. Additionally, in spite of essentially normal circadian locomotion cycle in both strains, activity levels and body temperature were both significantly higher in 2-month-old TgR mice during the first half of the dark phase (<xref ref-type="fig" rid="biomolecules-10-00848-f001">Figure 1</xref>F,G). The contribution of vestibular dysfunction and middle ear pathology to TgR circling behavior was excluded, as TgR mice displayed symmetric head orienting when touched with a probe at the shoulder and turned symmetrically toward an approaching edge. Oral stereotypy (e.g., chewing, biting or licking) was not evident in the TgR mice (<xref ref-type="app" rid="app1-biomolecules-10-00848">Supplementary Movie</xref> S2). We conclude that TgR mice displayed persistent SB characteristics, evident as circadian controlled motion hyperactivity, excessive circling behavior and motor asymmetry patterns which were subject to impaired control of their circadian behavior patterns.</p>
</sec>
<sec id="sec3dot2-biomolecules-10-00848">
<title>3.2. Muscarinic Stimulation Suppresses the Motor Hyperactivity but not the Locomotor Asymmetry Component of SB</title>
<p>To test if the SB patterns were due to the cholinergic impairments of TgR mice, we injected these mice with the cholinergic agonist pilocarpine. This agent, at an intravenously injected dose of 25 mg/kg, profoundly suppressed motor behavior in both FVB/N and TgR mice (<xref ref-type="fig" rid="biomolecules-10-00848-f002">Figure 2</xref> and <xref ref-type="app" rid="app1-biomolecules-10-00848">Supplementary Table S1</xref>). Due to the higher baseline locomotion time in TgR mice, this yielded a significant interaction of pilocarpine and transgene. However, pilocarpine showed no effect on the locomotor asymmetry component of the SB profile, with no interaction of drug and transgene in this context (<xref ref-type="app" rid="app1-biomolecules-10-00848">Supplementary Table S1</xref>), predicting that additional neurotransmission pathway(s) might be involved. Taken together, the prevalent behavioral differences between TgR and FVB/N mice, and the fact that these are manifested in multiple test conditions, suggested that these deficits did not reflect a low-level motor impairment. Rather, these findings could better be explained by a higher systematic deficit in neurotransmission pathway(s), which is what we tested next.</p>
</sec>
<sec id="sec3dot3-biomolecules-10-00848">
<title>3.3. hAChE-R Excess Does Not Disrupt Normal Cholinergic and Glutamatergic Pathways and Is Inversely Correlated with ChAT Expression</title>
<p>Given the cholinoceptive nature of the hippocampus and its key role in controlling navigation behavior [<xref ref-type="bibr" rid="B55-biomolecules-10-00848">55</xref>,<xref ref-type="bibr" rid="B56-biomolecules-10-00848">56</xref>], we have first addressed this brain region in our tests. Quantitative PCR demonstrated massive selective increases of the stress-induced AChE-R variant in the hippocampi of 10 weeks old TgR mice compared to controls, with more modest increases of both the synaptic AChE-S variant and of AChE-R in the prefrontal cortex (PFC, <xref ref-type="fig" rid="biomolecules-10-00848-f003">Figure 3</xref>A–C). Extending this analysis to the protein level, cholinergic neurons in TgR mice appeared normal in number and size and were successfully labeled for both the leading AChE-S protein and the stress-induced AChE-R variant (<xref ref-type="fig" rid="biomolecules-10-00848-f003">Figure 3</xref>D–F). Notably, TgR mice showed normal distribution of cholinergic ChAT-expressing neurons with symmetric distribution between the right and left hemispheres. However, numerous cholinergic neurons with intense ChAT expression did not express hAChE-R in the striatum, medial septum and diagonal band, indicating differential translation levels of this transcript in cholinergic neurons (<xref ref-type="fig" rid="biomolecules-10-00848-f003">Figure 3</xref>G,H,K). This also ruled out loss or impaired function of cholinergic neurons and hemispheric differences as potential causes for SB. Importantly, intensely hAChE-R-labeled neurons were denser in the medial striatum (128 ± 19 per sampled field of 100 µm<sup>2</sup>) than in the lateral striatum (25 ± 7 per sampled field, paired <italic>t</italic>-test (df = 7) = 6.8, <italic>p</italic> &lt; 0.0005), opposite to the gradient of cholinergic activity in the striatum [<xref ref-type="bibr" rid="B57-biomolecules-10-00848">57</xref>]. The nucleus basalis magnocellularis, brainstem and spinal cord (ventral horn) motor nuclei all included subsets of cholinergic neurons with less intense ChAT but pronounced hAChE-R expression (<xref ref-type="fig" rid="biomolecules-10-00848-f003">Figure 3</xref>I,J,L). TgR mice further showed inter-hemispheric symmetry and normal distribution of tyrosine hydroxylase-positive dopaminergic neurons, without AChE-R. Thus, the brains of TgR mice presented somewhat skewed cholinergic profiles, but with otherwise regular histopathology.</p>
</sec>
<sec id="sec3dot4-biomolecules-10-00848">
<title>3.4. AChE-R Distribution in Motor-Regulating Brain Regions</title>
<p>Multiple subsets of neurons in several brain regions of TgR mice showed an excess of both transgenic hAChE-R and murine mAChE-R mRNA, accompanied by enhanced immunolabeling of the (h)AChE-R protein. Typically, the neuronal cytoplasm, nucleus, and dendrite(s), but not axons, were stained (<xref ref-type="fig" rid="biomolecules-10-00848-f004">Figure 4</xref>A,B). In general, hAChE-R accumulation overlapped with that of the host gene, occurring in cholinoceptive regions that tend to express the primary synaptic AChE-S variant (e.g., cortex, hippocampus and striatum).</p>
<p>All TgR mice showed extensive hAChE-R expression in the neocortex, striatum, red nucleus and cerebellum, all of which are known to contribute to motor regulation [<xref ref-type="bibr" rid="B58-biomolecules-10-00848">58</xref>,<xref ref-type="bibr" rid="B59-biomolecules-10-00848">59</xref>], as well as in the anterior cingulate cortex, amygdala, hypothalamus and medial striatum, reported as being involved in the emotion-motor interface [<xref ref-type="bibr" rid="B60-biomolecules-10-00848">60</xref>,<xref ref-type="bibr" rid="B61-biomolecules-10-00848">61</xref>]. Some TgR mice also showed increased AChE-R expression in the striatum, lateral septum and most prominently in the hippocampus, structures known to participate in behaviorally-inhibitory pathways [<xref ref-type="bibr" rid="B62-biomolecules-10-00848">62</xref>,<xref ref-type="bibr" rid="B63-biomolecules-10-00848">63</xref>]. Neuronal activation was assessed by immunohistochemical detection of the immediate early gene c-fos, known to be increased under numerous insults [<xref ref-type="bibr" rid="B64-biomolecules-10-00848">64</xref>,<xref ref-type="bibr" rid="B65-biomolecules-10-00848">65</xref>]. Notably, the medial striatum, lateral septum and anterior cingulate cortex in TgR mice included fewer c-fos positive cells than in FVB/N mice (<xref ref-type="fig" rid="biomolecules-10-00848-f004">Figure 4</xref>C and <xref ref-type="table" rid="biomolecules-10-00848-t004">Table 4</xref>). Thus, the observed SB patterns could not be attributed to elevated c-Fos levels.</p>
</sec>
<sec id="sec3dot5-biomolecules-10-00848">
<title>3.5. RNA-Seq Reveals Modified CholinomiRs in TgR Hippocampi</title>
<p>The hippocampus coordinates numerous behavioral patterns [<xref ref-type="bibr" rid="B66-biomolecules-10-00848">66</xref>], and it readily reacts to altered cholinergic cues [<xref ref-type="bibr" rid="B67-biomolecules-10-00848">67</xref>] and shows corresponding changes in miRNAs [<xref ref-type="bibr" rid="B68-biomolecules-10-00848">68</xref>]. To explore such changes in the TgR hippocampus, we performed short RNA-sequencing of hippocampal RNAs from TgR mice and matched controls. A total of 36 miRNAs were differentially expressed (DE) in the TgR hippocampal RNA-seq datasets compared to FVB controls, and eight of these DE miRNAs target at least 5 cholinergic transcripts each (<xref ref-type="fig" rid="biomolecules-10-00848-f005">Figure 5</xref>A; dataset deposited as GEO GSE144022) [<xref ref-type="bibr" rid="B55-biomolecules-10-00848">55</xref>]). Notably, the downregulated cholinergic-targeted miRNAs formed a multi-level network with other miRNAs, considerably more complex than the network formed by the upregulated miRNAs (<xref ref-type="fig" rid="biomolecules-10-00848-f005">Figure 5</xref>B). Those included miR-125b which targets, among other mRNAs both AChE-R and the vesicular ACh transporter (VAChT) [<xref ref-type="bibr" rid="B41-biomolecules-10-00848">41</xref>], miR-370, the targets of which include the AKT signaling pathway [<xref ref-type="bibr" rid="B69-biomolecules-10-00848">69</xref>] and BMP2 [<xref ref-type="bibr" rid="B70-biomolecules-10-00848">70</xref>], and miR-204 which may inhibit the cholinergic-suppressible inflammation-associated NFkB signaling pathway [<xref ref-type="bibr" rid="B71-biomolecules-10-00848">71</xref>]. The modified miRNAs further formed intricate networks, suggesting that they may each affect the other modified miRNAs (<xref ref-type="fig" rid="biomolecules-10-00848-f005">Figure 5</xref>B). Intriguingly, no miRNAs were DE in the prefrontal cortex (PFC) of TgR mice. However, given the power of such network changes to exert neuro-modulation impacts across the brain [<xref ref-type="bibr" rid="B72-biomolecules-10-00848">72</xref>], we proceeded by outlining corresponding changes in mRNA transcripts of the prefrontal cortex, which communicates with the hippocampus.</p>
</sec>
<sec id="sec3dot6-biomolecules-10-00848">
<title>3.6. The TgR PFC Shows More Variable Cholinergic Transcripts than the Caudate Putamen</title>
<p>To further explore the cholinergic signaling-related brain routes, we compared the levels of cholinergic-associated transcripts between the striatal caudate-putamen (CP) and the PFC of FVB/N control and TgR mice (dataset deposited as GEO GSE31458). Intriguingly, the PFC showed more inter-individual variability for cholinergic and stress-related transcripts including CHRM3, CHRNA7, CNR1, DLG3, GRIN2A and SHANK3 compared to their CP expression patterns (<xref ref-type="fig" rid="biomolecules-10-00848-f006">Figure 6</xref>). The greater individual diversity of cholinergic-related and stress-associated genes in the PFC compared to the CP could be functionally relevant for the SB phenotype.</p>
</sec>
<sec id="sec3dot7-biomolecules-10-00848">
<title>3.7. Suppressed Glutamatergic Neurotransmission-Related Genes in the TgR PFC</title>
<p>We predicted that the miRNA changes in the TgR hippocampus reflect its cholinoceptive features; to test this hypothesis, we sought corresponding differences in miRNA-targeted coding transcripts within other brain regions that modulate the hippocampus via cholinergic signaling. Given the PFC’s capacity to send stimuli-related messages to the hippocampus [<xref ref-type="bibr" rid="B74-biomolecules-10-00848">74</xref>], we performed PFC transcriptomic analyses. We compared the FVB/N vs. FVB/N (C1/C2), TgR vs. TgR (R1/R2) and the four possible combinations of FVB/N vs. TgR profiles (<xref ref-type="fig" rid="biomolecules-10-00848-f007">Figure 7</xref>A). The two FVB/N preparations yielded highly similar profiles (<xref ref-type="fig" rid="biomolecules-10-00848-f007">Figure 7</xref>B, C2 vs. C1), with merely five genes showing a change. In contrast, the two TgR microarrays displayed higher variability, with 106 transcripts designated as DE (<xref ref-type="fig" rid="biomolecules-10-00848-f007">Figure 7</xref>B, R1 vs. R2). In comparison, PFC-expressed genes in TgR mice differed from those of FVB/N mice (<xref ref-type="fig" rid="biomolecules-10-00848-f007">Figure 7</xref>B, R1 vs. C1, R2 vs. C2 or the reciprocal comparisons) by 132, 388, 143, and 428 transcripts with robust changes (also, see <xref ref-type="fig" rid="biomolecules-10-00848-f007">Figure 7</xref>B for correlation coefficients (CC) between the absence/presence calls of each of the individual arrays), especially in glutamate-related functions.</p>
<p>The transcriptomic tests of coding mRNAs, followed by Gene Ontology analysis (GO [<xref ref-type="bibr" rid="B54-biomolecules-10-00848">54</xref>]) of the corresponding biological process and molecular function ontologies revealed several significantly downregulated cellular and organism level categories in the TgR PFC (<xref ref-type="fig" rid="biomolecules-10-00848-f007">Figure 7</xref>A). Most conspicuous were changes in transcription-related processes (e.g., DNA binding transcription factors, trans-acting transcription activators/repressors, hormone receptors and chromatin remodeling). Two major affected categories included synaptic transmission (<italic>p</italic> &lt; 2 × 10<sup>−5</sup>, 12 of 62 genes changed) and ion transport/channel activity-related processes (<italic>p</italic> &lt; 9 × 10<sup>−4</sup>, 18 of 238 changed). Suppressed molecular function categories included ionotropic glutamate receptor activity (1 × 10<sup>−3</sup>, 5/13) and glutamate-gated ion channel activity (<xref ref-type="fig" rid="biomolecules-10-00848-f007">Figure 7</xref>B). Within the category of synaptic transmission, we noted changes in CAMK2, associated with the control over long-term potentiation [<xref ref-type="bibr" rid="B75-biomolecules-10-00848">75</xref>], which is indeed modified in the TgR mouse [<xref ref-type="bibr" rid="B76-biomolecules-10-00848">76</xref>]; VAMP2, involved with synaptic transmission efficacy [<xref ref-type="bibr" rid="B77-biomolecules-10-00848">77</xref>] and WNT7B, regulating the WNT signaling pathway [<xref ref-type="bibr" rid="B78-biomolecules-10-00848">78</xref>] were also modified. The decrease in ion channel activity involved reductions in calcium, potassium, chloride and sodium channels, GABA transporter (GABRA3, [<xref ref-type="bibr" rid="B79-biomolecules-10-00848">79</xref>,<xref ref-type="bibr" rid="B80-biomolecules-10-00848">80</xref>]), the ATPase ATP 6V1A [<xref ref-type="bibr" rid="B81-biomolecules-10-00848">81</xref>] and glutamate decarboxylase (GAD2, [<xref ref-type="bibr" rid="B82-biomolecules-10-00848">82</xref>]) in addition to the glutamate receptor NR4A2 gene [<xref ref-type="bibr" rid="B83-biomolecules-10-00848">83</xref>]. These are all compatible with our findings of reduced glutamate receptor levels in cultured hippocampal neurons overexpressing AChE [<xref ref-type="bibr" rid="B84-biomolecules-10-00848">84</xref>,<xref ref-type="bibr" rid="B85-biomolecules-10-00848">85</xref>] and reciprocal to the changes induced by excess AChE-S in PFC neurons. The changed categories are noted in <xref ref-type="fig" rid="biomolecules-10-00848-f007">Figure 7</xref>B, and the changed transcripts are listed in <xref ref-type="app" rid="app1-biomolecules-10-00848">Supplementary Table S2</xref>.</p>
</sec>
<sec id="sec3dot8-biomolecules-10-00848">
<title>3.8. Validating Brain Region-Dependent Changes in Cholinergic and SB-Related Transcripts</title>
<p>To validate the PFC microarray findings and seek their relevance to the over-expressed AChE-R and the modified hippocampal miRNAs, we performed qPCR tests of selected relevant mRNA transcripts which are characteristic of the predictably modified pathways in hippocampi and PFC tissues from TgR and control mice. Notably, both the muscarinic receptor CHRM3 shown to be essential for REM sleep [<xref ref-type="bibr" rid="B86-biomolecules-10-00848">86</xref>] and the attention-related CHRM5 [<xref ref-type="bibr" rid="B87-biomolecules-10-00848">87</xref>] showed hippocampal but not PFC differences in TgR mice compared to FVB/N controls and to unmodified transcript controls (<xref ref-type="fig" rid="biomolecules-10-00848-f008">Figure 8</xref>). Additionally, we noted massive albeit bidirectional hippocampal changes in the autism-related transcripts of Grin2b, PTEN and SHANK3 [<xref ref-type="bibr" rid="B88-biomolecules-10-00848">88</xref>,<xref ref-type="bibr" rid="B89-biomolecules-10-00848">89</xref>,<xref ref-type="bibr" rid="B90-biomolecules-10-00848">90</xref>,<xref ref-type="bibr" rid="B91-biomolecules-10-00848">91</xref>], predicting behavioral differences; but not in the inflammation-associated CHRNA7, indicating limited relevance for brain inflammation. Notably, both miR-370-3p and miR-204-5p are known controllers of brain glia, indicating their potential relevance to the observed changes in the target transcripts. We conclude that perturbation of cholinergic/glutamatergic networks may induce stress-induced miRNA-mediated SB.</p>
</sec>
</sec>
<sec id="sec4-biomolecules-10-00848" sec-type="discussion">
<title>4. Discussion</title>
<p>TgR mice presented locomotor SB that appeared to be a repetition of pre-potent defensive motor responses to threat. Specifically, the running component paralleled running response under threat [<xref ref-type="bibr" rid="B43-biomolecules-10-00848">43</xref>,<xref ref-type="bibr" rid="B45-biomolecules-10-00848">45</xref>,<xref ref-type="bibr" rid="B92-biomolecules-10-00848">92</xref>], which was consistently accompanied by the TgR hyper-locomotion. This is compatible with the reported linkage between emotionality and lateralization of motor behavior [<xref ref-type="bibr" rid="B93-biomolecules-10-00848">93</xref>], which may be associated in TgR mice with locomotor-asymmetry and circling. Thus, we propose that in wild type mice, escape-mode defensive pre-potent motor responses may be subjected to inhibitory control; however, in the TgR mouse, these responses are released from inhibition as revealed by c-fos reduction in executive brain regions of the TgR emotional-motor interface.</p>
<p>Seeking the neuronal network origin of SB and its underlying molecular mechanisms, we studied short hippocampal and long PFC RNA transcripts in SB-expressing TgR mice over-expressing the stress-inducible soluble AChE-R variant, which accelerates acetylcholine degradation and suppresses cholinergic reactions. The transcriptomic analysis was performed on a mixed group of TgR mice with predicted inter-individual variability in their SB profiles. This indicates under-estimation of the impact of this transgene on those TgR mice presenting high level SB. We found TgR hippocampi to show 36 DE miRNAs, with 8 of those targeting cholinergic-related transcripts. Moreover, the PFCs of TgR mice, which showed no DE miRNAs, displayed 428 long DE mRNA transcripts, with a conspicuous decline of glutamatergic-related pathways (<italic>p</italic> &lt; 1 × 10<sup>−3</sup>) and pronounced changes in autism-related transcripts compared to FVB/N mice. We further noted excess of C-fos at motor behavior-regulating brain regions and of immune-labeled AChE-R in SB-regulating basal ganglia, limbic brain nuclei and the brain stem. This labeling pattern accompanied the SB profiles of TgR mice. Combined with the changes we found in hippocampal miRNAs and selected glutamatergic-related PFC transcripts, these findings may indicate miRNA-mediated perturbation of the delicate balance between cholinergic/glutamatergic networks as accompanying the impaired inhibitory control over defensive motor behavior which is causally involved in SB.</p>
<sec id="sec4dot1-biomolecules-10-00848">
<title>4.1. Modified Hippocampal miRNAs in TgR Mice with Altered Cholinergic Activities</title>
<p>Over-expression of the stress-inducible soluble AChE-R variant predicts excessive ACh hydrolysis and correspondingly impaired cholinergic transmission in several motor-related brain regions. This variant is over-expressed in the mammalian brain under stress responses (reviewed in [<xref ref-type="bibr" rid="B33-biomolecules-10-00848">33</xref>]). Therefore, we assumed that modified expression of cholinergic miRNAs might be involved. To test this prediction, we performed non-biased profiling of the short RNAs in TgR hippocampi compared to wild type FVB/N controls. This analysis indeed revealed 36 DE miRNAs, 8 of which affect cholinergic function (‘CholinomiRs’, [<xref ref-type="bibr" rid="B94-biomolecules-10-00848">94</xref>]). Those included miR-125b which targets both AChE-R and the vesicular acetylcholine transporter (VAChT) [<xref ref-type="bibr" rid="B41-biomolecules-10-00848">41</xref>], indicating that transgenic over-expression of AChE-R induced miRNA-mediated suppression of both the transgene itself and the cholinergic network that it interrupts in TgR brains. Other miRNAs that were affected are miR-370, which targets the AKT signaling pathway [<xref ref-type="bibr" rid="B69-biomolecules-10-00848">69</xref>] and BMP2 [<xref ref-type="bibr" rid="B70-biomolecules-10-00848">70</xref>]. Changes were also observed in miR-204, which inhibits the NFkB signaling pathway that is associated with inflammation and is suppressible by cholinergic inputs [<xref ref-type="bibr" rid="B71-biomolecules-10-00848">71</xref>]. Altogether, the impaired miRNA signaling in the TgR hippocampi suggests a causal involvement of the AChE-R variant in both the cholinergic pathway in general, and the SB profile of these mice in particular.</p>
</sec>
<sec id="sec4dot2-biomolecules-10-00848">
<title>4.2. Prefrontal Cortex and Striatal Transcriptomics of TgR vs FVB/N Mice</title>
<p>The hippocampal CholinomiR changes and the neuro-modulatory role of cholinergic neurotransmission [<xref ref-type="bibr" rid="B33-biomolecules-10-00848">33</xref>,<xref ref-type="bibr" rid="B95-biomolecules-10-00848">95</xref>] suggested the existence of further modifications in other brain regions. Notably, the PFC showed larger variability in cholinergic-related transcripts than the striatal caudate-putamen. Given the stress-related links of PFC functioning with the hippocampus, we proceeded by transcriptomic profiling of long RNAs in the PFC. This analysis revealed greater variability in PFC transcripts from TgR mice compared to their parent FVB/N strain. Specifically, we found the categories of both signal transduction and protein kinase C activation to be modified in the TgR PFC, which indicates that AChE-R may play an active role in modulating motor responses to stress. Additionally, the neuro-anatomical distribution of AChE-R overlapped with that of its partner kinase [<xref ref-type="bibr" rid="B96-biomolecules-10-00848">96</xref>], consistent with our previous studies showing intensified, PKC-mediated LTP responses in TgR mice [<xref ref-type="bibr" rid="B76-biomolecules-10-00848">76</xref>,<xref ref-type="bibr" rid="B97-biomolecules-10-00848">97</xref>]. Therefore, the variable neuroanatomical distribution of transgenic AChE-R may support the gene-environment interaction(s) accounting for the TgR SB phenotype. Furthermore, the altered synaptic regulation by AChE-R occurred in specific pathways involved with stress management, consistent with the overlap between AChE-R’s neuro-anatomical distribution and the distribution of stress-activated neuronal populations.</p>
</sec>
<sec id="sec4dot3-biomolecules-10-00848">
<title>4.3. Implications for SB Studies</title>
<p>Several studies support glutamatergic causation of SB. This centers on anatomical substrates within the striatum [<xref ref-type="bibr" rid="B16-biomolecules-10-00848">16</xref>,<xref ref-type="bibr" rid="B98-biomolecules-10-00848">98</xref>], and possibly other brain regions in the motor hierarchy. Such conclusions are mainly derived from clinical studies. For example, Tourette’s syndrome abnormalities involve interactions between the striatum and other brain regions [<xref ref-type="bibr" rid="B99-biomolecules-10-00848">99</xref>]. However, although animal model studies of spontaneous cage stereotypies [<xref ref-type="bibr" rid="B17-biomolecules-10-00848">17</xref>] associated captivity stress with SB, the anatomical substrate of SB in these models has not been elucidated yet. Our current study bridges the anatomical distribution of stress signals with the corresponding transcriptomic signals and the SB phenotype, suggesting that stress-induced changes in AChE-R distribution and in neuronal activation in the behavioral-motor interface may yield SB. Importantly, SB is not a single class of purposeless movement. Rather, we find that stress-related cholinergic signaling intensifies pre-potent escape-related locomotion while other motor behaviors such as rearing are reduced. That TgR mice display SB patterns under safety supports the notion of stress-induced restriction of their normal behavioral repertoire. Different types of stress may hence engage distinct pre-potent defensive motor responses and result in different forms of SB, with glutamate involved in some but not necessarily all aspects of SB.</p>
</sec>
<sec id="sec4dot4-biomolecules-10-00848">
<title>4.4. Clinical Relevance to Human SB</title>
<p>The elevated stress signaling [<xref ref-type="bibr" rid="B100-biomolecules-10-00848">100</xref>] and reduced inhibitory tone in executive brain regions of the emotional motor interface [<xref ref-type="bibr" rid="B101-biomolecules-10-00848">101</xref>,<xref ref-type="bibr" rid="B102-biomolecules-10-00848">102</xref>] in Tourette’s syndrome parallel our observations in TgR mice. The frequency and intensity of tics (a stereotypic motor pattern) displayed by Tourette’s patients increase under situations perceived as threatening [<xref ref-type="bibr" rid="B12-biomolecules-10-00848">12</xref>,<xref ref-type="bibr" rid="B13-biomolecules-10-00848">13</xref>]. In addition, striatal cholinergic activity is involved in both human SB and psychosis. Along with the cingulate and orbito-frontal cortex, the caudate nucleus serves as the major substrate for the effects of stress on glutamatergic pathways [<xref ref-type="bibr" rid="B103-biomolecules-10-00848">103</xref>]. Both the caudate and cingulate/prefrontal cortices are involved in the TgR model. Nevertheless, the movement sequences that comprise SB differ among mouse models, caged animals or psychiatric patients. While locomotor hyperactivity and circling behavior occur both in some psychiatric disorders [<xref ref-type="bibr" rid="B104-biomolecules-10-00848">104</xref>] and in TgR mice, several other SB movement sequences appear in psychiatric and developmental disorders [<xref ref-type="bibr" rid="B8-biomolecules-10-00848">8</xref>] but not in TgR mice. Nevertheless, the clinical relevance of cholinergic stress signaling to SB in psychiatric disorders is supported by our finding that in human blood tests, AChE-R levels increase with state anxiety [<xref ref-type="bibr" rid="B105-biomolecules-10-00848">105</xref>]. We conclude that SB reflects a multitude of pre-potent movement sequences that escape inhibitory control, that are often stress-related and that vary depending on the neural substrates involved in the given psychiatric disorder. While we are aware of the limitations of this study, which largely presents an association phenomenon rather than a conclusive mechanism of action, it may be naïve to link the complex SB phenomenon to a single splice variant of a single enzyme; nevertheless, the broad distribution of cholinergic stress signaling points to AChE-R as an important candidate to investigate in psychiatric disorders with stereotypic behaviors.</p>
</sec>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>The authors are grateful to Osnat Cohen, Eugenia Kovalev and Estelle R. Bennett, The Hebrew University and Eyal Soreq, Imperial College, London for their contributions towards this study.</p>
</ack>
<app-group>
<app id="app1-biomolecules-10-00848">
<title>Supplementary Materials</title>
<p>The following are available online at <uri xlink:href="https://www.mdpi.com/2218-273X/10/6/848/s1">https://www.mdpi.com/2218-273X/10/6/848/s1</uri>, Figure S1: TgR mice show modified circling behaviour. Table S1: Pharmacological experiments in the open field paradigm: cholinergic impact. Video S1: TgR mice show motor hyperactivity in forced swim. Video S2: TgR mice display symmetric head orienting.</p>
<supplementary-material content-type="local-data" id="biomolecules-10-00848-s001">
<media xlink:href="biomolecules-10-00848-s001.zip">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</app>
</app-group>
<notes>
<title>Author Contributions</title>
<p>G.M. molecular experimental work, writing and investigation; S.S. behavioural work, writing and editing, funding acquisition; N.M. analysis and visualisation; A.M.H. quantitative PCR tests; D.S.G. supervision and project administration; R.Y. reviewing, editing; Y.B.-S. molecular analyses and reviewing; H.S. supervision, guidance and writing, funding acquisition. All authors have read and agreed to the published version of the manuscript.</p>
</notes>
<notes>
<title>Funding</title>
<p>The authors acknowledge support of this study by the European Research Council Advanced Award 321501 and the Israel Science Foundation Grant no. 1016/18 (to HS), the NOFAR Israel Innovations Authority Grant No. 65812 (to DSG) and the Israel Science Foundation Grant no. 484/2 (to SS).</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflict of interest.</p>
</notes>
<ref-list>
<title>References</title>
<ref id="B1-biomolecules-10-00848">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Salgado</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fahn</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>The characterization and outcome of stereotypical movements in nonautistic children</article-title>
<source/>Mov. Disord.
          <year>1997</year>
<volume>12</volume>
<fpage>47</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="doi">10.1002/mds.870120109</pub-id>
<pub-id pub-id-type="pmid">8990053</pub-id>
</element-citation>
</ref>
<ref id="B2-biomolecules-10-00848">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stern</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Silbersweig</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Chee</surname>
<given-names>K.Y.</given-names>
</name>
<name>
<surname>Holmes</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Trimble</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Frith</surname>
<given-names>C.D.</given-names>
</name>
<name>
<surname>Frackowiak</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Dolan</surname>
<given-names>R.J.</given-names>
</name>
</person-group>
<article-title>A functional neuroanatomy of tics in Tourette syndrome</article-title>
<source/>Arch. Gen. Psychiatry
          <year>2000</year>
<volume>57</volume>
<fpage>741</fpage>
<lpage>748</lpage>
<pub-id pub-id-type="doi">10.1001/archpsyc.57.8.741</pub-id>
<pub-id pub-id-type="pmid">10920461</pub-id>
</element-citation>
</ref>
<ref id="B3-biomolecules-10-00848">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peralta</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Cuesta</surname>
<given-names>M.J.</given-names>
</name>
</person-group>
<article-title>Motor features in psychotic disorders. I. Factor structure and clinical correlates</article-title>
<source/>Schizophr. Res.
          <year>2001</year>
<volume>47</volume>
<fpage>107</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="doi">10.1016/S0920-9964(00)00013-X</pub-id>
<pub-id pub-id-type="pmid">11278127</pub-id>
</element-citation>
</ref>
<ref id="B4-biomolecules-10-00848">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pierce</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Courchesne</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Evidence for a cerebellar role in reduced exploration and stereotyped behavior in autism</article-title>
<source/>Biol. Psychiatry
          <year>2001</year>
<volume>49</volume>
<fpage>655</fpage>
<lpage>664</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-3223(00)01008-8</pub-id>
<pub-id pub-id-type="pmid">11313033</pub-id>
</element-citation>
</ref>
<ref id="B5-biomolecules-10-00848">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turner</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Annotation: Repetitive behaviour in autism: A review of psychological research</article-title>
<source/>J. Child Psychol. Psychiatry
          <year>1999</year>
<volume>40</volume>
<fpage>839</fpage>
<lpage>849</lpage>
<pub-id pub-id-type="doi">10.1111/1469-7610.00502</pub-id>
<pub-id pub-id-type="pmid">10509879</pub-id>
</element-citation>
</ref>
<ref id="B6-biomolecules-10-00848">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kenworthy</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Charnas</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Evidence for a discrete behavioral phenotype in the oculocerebrorenal syndrome of Lowe</article-title>
<source/>Am. J. Med. Genet.
          <year>1995</year>
<volume>59</volume>
<fpage>283</fpage>
<lpage>290</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.1320590304</pub-id>
<pub-id pub-id-type="pmid">8599350</pub-id>
</element-citation>
</ref>
<ref id="B7-biomolecules-10-00848">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaytser</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Berry-Kravis</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ouyang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Doll</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>D.A.</given-names>
</name>
</person-group>
<article-title>Motor stereotypies in fragile X syndrome</article-title>
<source/>J. Pediatr. Neurol.
          <year>2014</year>
<volume>12</volume>
<fpage>29</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="doi">10.3233/JPN-140635</pub-id>
</element-citation>
</ref>
<ref id="B8-biomolecules-10-00848">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neul</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>H.Y.</given-names>
</name>
</person-group>
<article-title>Rett syndrome: A prototypical neurodevelopmental disorder</article-title>
<source/>Neuroscientist
          <year>2004</year>
<volume>10</volume>
<fpage>118</fpage>
<lpage>128</lpage>
<pub-id pub-id-type="doi">10.1177/1073858403260995</pub-id>
<pub-id pub-id-type="pmid">15070486</pub-id>
</element-citation>
</ref>
<ref id="B9-biomolecules-10-00848">
<label>9.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Sadock</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Kaplan</surname>
<given-names>H.I.</given-names>
</name>
<name>
<surname>Sadock</surname>
<given-names>V.A.</given-names>
</name>
</person-group>
<source/>Kaplan—Sadock’s Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry
          <edition>9th ed.</edition>
<publisher-name>Lippincott Williams &amp; Wilkins</publisher-name>
<publisher-loc>Philadelphia, PA, USA</publisher-loc>
<year>2003</year>
<fpage>1460</fpage>
</element-citation>
</ref>
<ref id="B10-biomolecules-10-00848">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGrath</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Parks</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Burton</surname>
<given-names>F.H.</given-names>
</name>
</person-group>
<article-title>Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette’s syndrome and obsessive-compulsive disorder</article-title>
<source/>Brain Res.
          <year>2000</year>
<volume>877</volume>
<fpage>23</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-8993(00)02646-9</pub-id>
<pub-id pub-id-type="pmid">10980239</pub-id>
</element-citation>
</ref>
<ref id="B11-biomolecules-10-00848">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saka</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Graybiel</surname>
<given-names>A.M.</given-names>
</name>
</person-group>
<article-title>Pathophysiology of Tourette’s syndrome: Striatal pathways revisited</article-title>
<source/>Brain Dev.
          <year>2003</year>
<volume>25</volume>
<fpage>S15</fpage>
<lpage>S19</lpage>
<pub-id pub-id-type="doi">10.1016/S0387-7604(03)90002-7</pub-id>
<pub-id pub-id-type="pmid">14980366</pub-id>
</element-citation>
</ref>
<ref id="B12-biomolecules-10-00848">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoekstra</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Steenhuis</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Kallenberg</surname>
<given-names>C.G.</given-names>
</name>
<name>
<surname>Minderaa</surname>
<given-names>R.B.</given-names>
</name>
</person-group>
<article-title>Association of small life events with self reports of tic severity in pediatric and adult tic disorder patients: A prospective longitudinal study</article-title>
<source/>J. Clin. Psychiatry
          <year>2004</year>
<volume>65</volume>
<fpage>426</fpage>
<lpage>431</lpage>
<pub-id pub-id-type="doi">10.4088/JCP.v65n0320</pub-id>
<pub-id pub-id-type="pmid">15096084</pub-id>
</element-citation>
</ref>
<ref id="B13-biomolecules-10-00848">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wood</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Klebba</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gbadebo</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Lichter</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kurlan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Pilot study of effect of emotional stimuli on tic severity in children with Tourette’s syndrome</article-title>
<source/>Mov. Disord.
          <year>2003</year>
<volume>18</volume>
<fpage>1392</fpage>
<lpage>1395</lpage>
<pub-id pub-id-type="doi">10.1002/mds.10552</pub-id>
<pub-id pub-id-type="pmid">14639691</pub-id>
</element-citation>
</ref>
<ref id="B14-biomolecules-10-00848">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKeown</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Moreno</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>V.L.</given-names>
</name>
<name>
<surname>Ribera</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Downes</surname>
<given-names>G.B.</given-names>
</name>
</person-group>
<article-title>Disruption of Eaat2b, a glutamate transporter, results in abnormal motor behaviors in developing zebrafish</article-title>
<source/>Dev. Biol
          <year>2012</year>
<volume>362</volume>
<fpage>162</fpage>
<lpage>171</lpage>
<pub-id pub-id-type="doi">10.1016/j.ydbio.2011.11.001</pub-id>
<pub-id pub-id-type="pmid">22094018</pub-id>
</element-citation>
</ref>
<ref id="B15-biomolecules-10-00848">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Ryu</surname>
<given-names>I.S.</given-names>
</name>
<name>
<surname>Sohn</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Choe</surname>
<given-names>E.S.</given-names>
</name>
</person-group>
<article-title>Interactions of Glutamatergic Neurotransmission and Brain-Derived Neurotrophic Factor in the Regulation of Behaviors after Nicotine Administration</article-title>
<source/>Int. J. Mol. Sci.
          <year>2019</year>
<volume>20</volume>
<elocation-id>2943</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms20122943</pub-id>
</element-citation>
</ref>
<ref id="B16-biomolecules-10-00848">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Canales</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Graybiel</surname>
<given-names>A.M.</given-names>
</name>
</person-group>
<article-title>A measure of striatal function predicts motor stereotypy</article-title>
<source/>Nat. Neurosci.
          <year>2000</year>
<volume>3</volume>
<fpage>377</fpage>
<lpage>383</lpage>
<pub-id pub-id-type="doi">10.1038/73949</pub-id>
<pub-id pub-id-type="pmid">10725928</pub-id>
</element-citation>
</ref>
<ref id="B17-biomolecules-10-00848">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garner</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>G.J.</given-names>
</name>
</person-group>
<article-title>Evidence for a relationship between cage stereotypies and behavioural disinhibition in laboratory rodents</article-title>
<source/>Behav. Brain Res.
          <year>2002</year>
<volume>136</volume>
<fpage>83</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.1016/S0166-4328(02)00111-0</pub-id>
<pub-id pub-id-type="pmid">12385793</pub-id>
</element-citation>
</ref>
<ref id="B18-biomolecules-10-00848">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mason</surname>
<given-names>W.A.</given-names>
</name>
</person-group>
<article-title>Effects of social interaction on well-being: Development aspects</article-title>
<source/>Lab. Anim. Sci.
          <year>1991</year>
<volume>41</volume>
<fpage>323</fpage>
<lpage>328</lpage>
<pub-id pub-id-type="pmid">1658478</pub-id>
</element-citation>
</ref>
<ref id="B19-biomolecules-10-00848">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X.Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Schafer</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Shieh</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Burke</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>T.E.</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Seasholtz</surname>
<given-names>A.F.</given-names>
</name>
<name>
<surname>Akil</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Glucocorticoid receptor overexpression in forebrain: A mouse model of increased emotional lability</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2004</year>
<volume>101</volume>
<fpage>11851</fpage>
<lpage>11856</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0402208101</pub-id>
<pub-id pub-id-type="pmid">15280545</pub-id>
</element-citation>
</ref>
<ref id="B20-biomolecules-10-00848">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wurbel</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Stauffacher</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Prevention of stereotypy in laboratory mice: Effects on stress physiology and behaviour</article-title>
<source/>Physiol. Behav.
          <year>1996</year>
<volume>59</volume>
<fpage>1163</fpage>
<lpage>1170</lpage>
<pub-id pub-id-type="doi">10.1016/0031-9384(95)02268-6</pub-id>
<pub-id pub-id-type="pmid">8737907</pub-id>
</element-citation>
</ref>
<ref id="B21-biomolecules-10-00848">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Powell</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Bodfish</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>T.W.</given-names>
</name>
<name>
<surname>Golden</surname>
<given-names>R.N.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>M.H.</given-names>
</name>
</person-group>
<article-title>Growth differences associated with compulsive and stereotyped behavior disorders in adults with mental retardation</article-title>
<source/>Anxiety
          <year>1996</year>
<volume>2</volume>
<fpage>90</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="doi">10.1002/(SICI)1522-7154(1996)2:2&lt;90::AID-ANXI5&gt;3.0.CO;2-H</pub-id>
<pub-id pub-id-type="pmid">9160607</pub-id>
</element-citation>
</ref>
<ref id="B22-biomolecules-10-00848">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verhoeven</surname>
<given-names>W.M.</given-names>
</name>
<name>
<surname>Tuinier</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>van den Berg</surname>
<given-names>Y.W.</given-names>
</name>
<name>
<surname>Coppus</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Fekkes</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pepplinkhuizen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Thijssen</surname>
<given-names>J.H.</given-names>
</name>
</person-group>
<article-title>Stress and self-injurious behavior; hormonal and serotonergic parameters in mentally retarded subjects</article-title>
<source/>Pharmacopsychiatry
          <year>1999</year>
<volume>32</volume>
<fpage>13</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1055/s-2007-979183</pub-id>
<pub-id pub-id-type="pmid">10071178</pub-id>
</element-citation>
</ref>
<ref id="B23-biomolecules-10-00848">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Popoli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>McEwen</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Sanacora</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>The stressed synapse: The impact of stress and glucocorticoids on glutamate transmission</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2011</year>
<volume>13</volume>
<fpage>22</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="doi">10.1038/nrn3138</pub-id>
<pub-id pub-id-type="pmid">22127301</pub-id>
</element-citation>
</ref>
<ref id="B24-biomolecules-10-00848">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bloomfield</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>McCutcheon</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Kempton</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Freeman</surname>
<given-names>T.P.</given-names>
</name>
<name>
<surname>Howes</surname>
<given-names>O.</given-names>
</name>
</person-group>
<article-title>The effects of psychosocial stress on dopaminergic function and the acute stress response</article-title>
<source/>Elife
          <year>2019</year>
<volume>8</volume>
<pub-id pub-id-type="doi">10.7554/eLife.46797</pub-id>
<pub-id pub-id-type="pmid">31711569</pub-id>
</element-citation>
</ref>
<ref id="B25-biomolecules-10-00848">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cox</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Metherate</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ashe</surname>
<given-names>J.H.</given-names>
</name>
</person-group>
<article-title>Modulation of cellular excitability in neocortex: Muscarinic receptor and second messenger-mediated actions of acetylcholine</article-title>
<source/>Synapse
          <year>1994</year>
<volume>16</volume>
<fpage>123</fpage>
<lpage>136</lpage>
<pub-id pub-id-type="doi">10.1002/syn.890160206</pub-id>
<pub-id pub-id-type="pmid">7910986</pub-id>
</element-citation>
</ref>
<ref id="B26-biomolecules-10-00848">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Day</surname>
<given-names>L.B.</given-names>
</name>
<name>
<surname>Schallert</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Anticholinergic effects on acquisition of place learning in the Morris water task: Spatial mapping deficit or inability to inhibit nonplace strategies?</article-title>
<source/>Behav. Neurosci.
          <year>1996</year>
<volume>110</volume>
<fpage>998</fpage>
<lpage>1005</lpage>
<pub-id pub-id-type="doi">10.1037/0735-7044.110.5.998</pub-id>
<pub-id pub-id-type="pmid">8919002</pub-id>
</element-citation>
</ref>
<ref id="B27-biomolecules-10-00848">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaneko</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hikida</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ichinose</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nagatsu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kreitman</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Pastan</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Nakanishi</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Synaptic integration mediated by striatal cholinergic interneurons in basal ganglia function</article-title>
<source/>Science
          <year>2000</year>
<volume>289</volume>
<fpage>633</fpage>
<lpage>637</lpage>
<pub-id pub-id-type="doi">10.1126/science.289.5479.633</pub-id>
<pub-id pub-id-type="pmid">10915629</pub-id>
</element-citation>
</ref>
<ref id="B28-biomolecules-10-00848">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaufer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Seidman</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Soreq</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Acute stress facilitates long-lasting changes in cholinergic gene expression</article-title>
<source/>Nature
          <year>1998</year>
<volume>393</volume>
<fpage>373</fpage>
<lpage>377</lpage>
<pub-id pub-id-type="doi">10.1038/30741</pub-id>
<pub-id pub-id-type="pmid">9620801</pub-id>
</element-citation>
</ref>
<ref id="B29-biomolecules-10-00848">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meshorer</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Erb</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gazit</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pavlovsky</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kaufer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Glick</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ben-Arie</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Soreq</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Alternative splicing and neuritic mRNA translocation under long-term neuronal hypersensitivity</article-title>
<source/>Science
          <year>2002</year>
<volume>295</volume>
<fpage>508</fpage>
<lpage>512</lpage>
<pub-id pub-id-type="doi">10.1126/science.1066752</pub-id>
<pub-id pub-id-type="pmid">11799248</pub-id>
</element-citation>
</ref>
<ref id="B30-biomolecules-10-00848">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meshorer</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Soreq</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Virtues and woes of AChE alternative splicing in stress-related neuropathologies</article-title>
<source/>Trends Neurosci.
          <year>2006</year>
<volume>29</volume>
<fpage>216</fpage>
<lpage>224</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2006.02.005</pub-id>
<pub-id pub-id-type="pmid">16516310</pub-id>
</element-citation>
</ref>
<ref id="B31-biomolecules-10-00848">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Picconi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Passino</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sgobio</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bonsi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Barone</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Ghiglieri</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Pisani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bernardi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ammassari-Teule</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Calabresi</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Plastic and behavioral abnormalities in experimental Huntington’s disease: A crucial role for cholinergic interneurons</article-title>
<source/>Neurobiol. Dis.
          <year>2006</year>
<volume>22</volume>
<fpage>143</fpage>
<lpage>152</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2005.10.009</pub-id>
<pub-id pub-id-type="pmid">16326108</pub-id>
</element-citation>
</ref>
<ref id="B32-biomolecules-10-00848">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sklan</surname>
<given-names>E.H.</given-names>
</name>
<name>
<surname>Berson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Birikh</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Gutnick</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Shahar</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Shoham</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Soreq</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Acetylcholinesterase Modulates Stress-Induced Motor Responses Through Catalytic and Noncatalytic Properties</article-title>
<source/>Biol. Psychiatry
          <year>2006</year>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2006.03.080</pub-id>
<pub-id pub-id-type="pmid">16904653</pub-id>
</element-citation>
</ref>
<ref id="B33-biomolecules-10-00848">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soreq</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Checks and balances on cholinergic signaling in brain and body function</article-title>
<source/>Trends Neurosci.
          <year>2015</year>
<volume>38</volume>
<fpage>448</fpage>
<lpage>458</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2015.05.007</pub-id>
<pub-id pub-id-type="pmid">26100140</pub-id>
</element-citation>
</ref>
<ref id="B34-biomolecules-10-00848">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soreq</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Seidman</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Acetylcholinesterase—New roles for an old actor</article-title>
<source/>Nat. Rev. Neurosci.
          <year>2001</year>
<volume>2</volume>
<fpage>294</fpage>
<lpage>302</lpage>
<pub-id pub-id-type="doi">10.1038/35067589</pub-id>
<pub-id pub-id-type="pmid">11283752</pub-id>
</element-citation>
</ref>
<ref id="B35-biomolecules-10-00848">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Filipowicz</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Bhattacharyya</surname>
<given-names>S.N.</given-names>
</name>
<name>
<surname>Sonenberg</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight?</article-title>
<source/>Nat. Rev. Genet.
          <year>2008</year>
<volume>9</volume>
<fpage>102</fpage>
<lpage>114</lpage>
<pub-id pub-id-type="doi">10.1038/nrg2290</pub-id>
<pub-id pub-id-type="pmid">18197166</pub-id>
</element-citation>
</ref>
<ref id="B36-biomolecules-10-00848">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGeary</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>K.S.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>C.Y.</given-names>
</name>
<name>
<surname>Pham</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Bisaria</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kelley</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Bartel</surname>
<given-names>D.P.</given-names>
</name>
</person-group>
<article-title>The biochemical basis of microRNA targeting efficacy</article-title>
<source/>Science
          <year>2019</year>
<volume>366</volume>
<pub-id pub-id-type="doi">10.1126/science.aav1741</pub-id>
</element-citation>
</ref>
<ref id="B37-biomolecules-10-00848">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bartel</surname>
<given-names>D.P.</given-names>
</name>
</person-group>
<article-title>Metazoan MicroRNAs</article-title>
<source/>Cell
          <year>2018</year>
<volume>173</volume>
<fpage>20</fpage>
<lpage>51</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2018.03.006</pub-id>
<pub-id pub-id-type="pmid">29570994</pub-id>
</element-citation>
</ref>
<ref id="B38-biomolecules-10-00848">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>C.Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D.F.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q.H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.R.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.S.</given-names>
</name>
</person-group>
<article-title>Overexpression of microRNA-301b accelerates hippocampal microglia activation and cognitive impairment in mice with depressive-like behavior through the NF-kappaB signaling pathway</article-title>
<source/>Cell Death Dis.
          <year>2019</year>
<volume>10</volume>
<fpage>316</fpage>
<pub-id pub-id-type="doi">10.1038/s41419-019-1522-4</pub-id>
<pub-id pub-id-type="pmid">30962417</pub-id>
</element-citation>
</ref>
<ref id="B39-biomolecules-10-00848">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tavakolizadeh</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Roshanaei</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Salmaninejad</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yari</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nahand</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Sarkarizi</surname>
<given-names>H.K.</given-names>
</name>
<name>
<surname>Mousavi</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Salarinia</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rahmati</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mousavi</surname>
<given-names>S.F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MicroRNAs and exosomes in depression: Potential diagnostic biomarkers</article-title>
<source/>J. Cell Biochem.
          <year>2018</year>
<volume>119</volume>
<fpage>3783</fpage>
<lpage>3797</lpage>
<pub-id pub-id-type="doi">10.1002/jcb.26599</pub-id>
<pub-id pub-id-type="pmid">29236313</pub-id>
</element-citation>
</ref>
<ref id="B40-biomolecules-10-00848">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ching</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Ahmad-Annuar</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>A Perspective on the Role of microRNA-128 Regulation in Mental and Behavioral Disorders</article-title>
<source/>Front. Cell Neurosci.
          <year>2015</year>
<volume>9</volume>
<fpage>465</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2015.00465</pub-id>
<pub-id pub-id-type="pmid">26696825</pub-id>
</element-citation>
</ref>
<ref id="B41-biomolecules-10-00848">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nadorp</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Soreq</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Predicted overlapping microRNA regulators of acetylcholine packaging and degradation in neuroinflammation-related disorders</article-title>
<source/>Front. Mol. Neurosci.
          <year>2014</year>
<volume>7</volume>
<fpage>9</fpage>
<pub-id pub-id-type="doi">10.3389/fnmol.2014.00009</pub-id>
<pub-id pub-id-type="pmid">24574962</pub-id>
</element-citation>
</ref>
<ref id="B42-biomolecules-10-00848">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allman</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Hakeem</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Erwin</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Nimchinsky</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hof</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>The anterior cingulate cortex. The evolution of an interface between emotion and cognition</article-title>
<source/>Ann. N. Y. Acad. Sci.
          <year>2001</year>
<volume>935</volume>
<fpage>107</fpage>
<lpage>117</lpage>
<pub-id pub-id-type="doi">10.1111/j.1749-6632.2001.tb03476.x</pub-id>
<pub-id pub-id-type="pmid">11411161</pub-id>
</element-citation>
</ref>
<ref id="B43-biomolecules-10-00848">
<label>43.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Gray</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>McNaughton</surname>
<given-names>N.</given-names>
</name>
</person-group>
<source/>The Neuropsychology of Anxiety: An Enquiry into the Functions of the Septo-Hippocampal System
          <edition>2nd ed.</edition>
<publisher-name>Oxford University Press</publisher-name>
<publisher-loc>New York, NY, USA</publisher-loc>
<year>2000</year>
<fpage>424</fpage>
</element-citation>
</ref>
<ref id="B44-biomolecules-10-00848">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haber</surname>
<given-names>S.N.</given-names>
</name>
<name>
<surname>Fudge</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>McFarland</surname>
<given-names>N.R.</given-names>
</name>
</person-group>
<article-title>Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum</article-title>
<source/>J. Neurosci.
          <year>2000</year>
<volume>20</volume>
<fpage>2369</fpage>
<lpage>2382</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-06-02369.2000</pub-id>
<pub-id pub-id-type="pmid">10704511</pub-id>
</element-citation>
</ref>
<ref id="B45-biomolecules-10-00848">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>LeDoux</surname>
<given-names>J.E.</given-names>
</name>
</person-group>
<article-title>Emotion, memory and the brain</article-title>
<source/>Sci. Am.
          <year>1994</year>
<volume>270</volume>
<fpage>50</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="doi">10.1038/scientificamerican0694-50</pub-id>
<pub-id pub-id-type="pmid">8023118</pub-id>
</element-citation>
</ref>
<ref id="B46-biomolecules-10-00848">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keay</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Bandler</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Parallel circuits mediating distinct emotional coping reactions to different types of stress</article-title>
<source/>Neurosci. Biobehav. Rev.
          <year>2001</year>
<volume>25</volume>
<fpage>669</fpage>
<lpage>678</lpage>
<pub-id pub-id-type="doi">10.1016/S0149-7634(01)00049-5</pub-id>
<pub-id pub-id-type="pmid">11801292</pub-id>
</element-citation>
</ref>
<ref id="B47-biomolecules-10-00848">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaczmarek</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chaudhuri</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Sensory regulation of immediate-early gene expression in mammalian visual cortex: Implications for functional mapping and neural plasticity</article-title>
<source/>Brain Res. Brain Res. Rev.
          <year>1997</year>
<volume>23</volume>
<fpage>237</fpage>
<lpage>256</lpage>
<pub-id pub-id-type="doi">10.1016/S0165-0173(97)00005-2</pub-id>
<pub-id pub-id-type="pmid">9164673</pub-id>
</element-citation>
</ref>
<ref id="B48-biomolecules-10-00848">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dori</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Silverman</surname>
<given-names>W.F.</given-names>
</name>
<name>
<surname>Pollack</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Soreq</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Functional manipulations of acetylcholinesterase splice variants highlight alternative splicing contributions to murine neocortical development</article-title>
<source/>Cereb. Cortex
          <year>2005</year>
<volume>15</volume>
<fpage>419</fpage>
<lpage>430</lpage>
<pub-id pub-id-type="doi">10.1093/cercor/bhh145</pub-id>
<pub-id pub-id-type="pmid">15749986</pub-id>
</element-citation>
</ref>
<ref id="B49-biomolecules-10-00848">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Erb</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ginzberg</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pollak</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Seidman</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shoham</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yirmiya</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Soreq</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Neuronal overexpression of ‘readthrough’ acetylcholinesterase is associated with antisense-suppressible behavioral impairments</article-title>
<source/>Mol. Psychiatry
          <year>2002</year>
<volume>7</volume>
<fpage>874</fpage>
<lpage>885</lpage>
<pub-id pub-id-type="doi">10.1038/sj.mp.4001103</pub-id>
<pub-id pub-id-type="pmid">12232781</pub-id>
</element-citation>
</ref>
<ref id="B50-biomolecules-10-00848">
<label>50.</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<name>
<surname>Andrews</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>FastQC: A Quality Control Tool for High Throughput Sequence Data</article-title>
<comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.babraham.ac.uk/projects/fastqc">http://www.bioinformatics.babraham.ac.uk/projects/fastqc</ext-link></comment>
<date-in-citation content-type="access-date" iso-8601-date="2010-01-12">(accessed on 12 January 2010)</date-in-citation>
</element-citation>
</ref>
<ref id="B51-biomolecules-10-00848">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>W.C.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>F.M.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>W.C.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>K.Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H.D.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>N.S.</given-names>
</name>
</person-group>
<article-title>miRExpress: Analyzing high-throughput sequencing data for profiling microRNA expression</article-title>
<source/>BMC Bioinform.
          <year>2009</year>
<volume>10</volume>
<elocation-id>328</elocation-id>
<pub-id pub-id-type="doi">10.1186/1471-2105-10-328</pub-id>
</element-citation>
</ref>
<ref id="B52-biomolecules-10-00848">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Love</surname>
<given-names>M.I.</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Anders</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>
<source/>Genome Biol.
          <year>2014</year>
<volume>15</volume>
<fpage>550</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id>
<pub-id pub-id-type="pmid">25516281</pub-id>
</element-citation>
</ref>
<ref id="B53-biomolecules-10-00848">
<label>53.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Team</surname>
<given-names>R.C.</given-names>
</name>
</person-group>
<source/>R: A Language and Environment for Statistical Computing
          <publisher-name>Team R.C</publisher-name>
<publisher-loc>Vienna, Austria</publisher-loc>
<year>2013</year>
</element-citation>
</ref>
<ref id="B54-biomolecules-10-00848">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beissbarth</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Speed</surname>
<given-names>T.P.</given-names>
</name>
</person-group>
<article-title>GOstat: Find statistically overrepresented Gene Ontologies within a group of genes</article-title>
<source/>Bioinformatics
          <year>2004</year>
<volume>20</volume>
<fpage>1464</fpage>
<lpage>1465</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/bth088</pub-id>
<pub-id pub-id-type="pmid">14962934</pub-id>
</element-citation>
</ref>
<ref id="B55-biomolecules-10-00848">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chanales</surname>
<given-names>A.J.H.</given-names>
</name>
<name>
<surname>Oza</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Favila</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Kuhl</surname>
<given-names>B.A.</given-names>
</name>
</person-group>
<article-title>Overlap among Spatial Memories Triggers Repulsion of Hippocampal Representations</article-title>
<source/>Curr. Biol.
          <year>2017</year>
<volume>27</volume>
<fpage>2307</fpage>
<lpage>2317</lpage>
<pub-id pub-id-type="doi">10.1016/j.cub.2017.06.057</pub-id>
<pub-id pub-id-type="pmid">28736170</pub-id>
</element-citation>
</ref>
<ref id="B56-biomolecules-10-00848">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mineur</surname>
<given-names>Y.S.</given-names>
</name>
<name>
<surname>Obayemi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wigestrand</surname>
<given-names>M.B.</given-names>
</name>
<name>
<surname>Fote</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Calarco</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Picciotto</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety-and depression-like behavior</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2013</year>
<volume>110</volume>
<fpage>3573</fpage>
<lpage>3578</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1219731110</pub-id>
<pub-id pub-id-type="pmid">23401542</pub-id>
</element-citation>
</ref>
<ref id="B57-biomolecules-10-00848">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burke</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Karanas</surname>
<given-names>A.L.</given-names>
</name>
</person-group>
<article-title>Demonstration of a medial to lateral gradient in the density of cholinergic neuropil in the rat striatum</article-title>
<source/>Neurosci. Lett.
          <year>1990</year>
<volume>108</volume>
<fpage>58</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1016/0304-3940(90)90706-F</pub-id>
<pub-id pub-id-type="pmid">2304638</pub-id>
</element-citation>
</ref>
<ref id="B58-biomolecules-10-00848">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kravitz</surname>
<given-names>A.V.</given-names>
</name>
<name>
<surname>Kreitzer</surname>
<given-names>A.C.</given-names>
</name>
</person-group>
<article-title>Striatal mechanisms underlying movement, reinforcement, and punishment</article-title>
<source/>Physiology
          <year>2012</year>
<volume>27</volume>
<fpage>167</fpage>
<lpage>177</lpage>
<pub-id pub-id-type="doi">10.1152/physiol.00004.2012</pub-id>
<pub-id pub-id-type="pmid">22689792</pub-id>
</element-citation>
</ref>
<ref id="B59-biomolecules-10-00848">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bostan</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Dum</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Strick</surname>
<given-names>P.L.</given-names>
</name>
</person-group>
<article-title>The basal ganglia communicate with the cerebellum</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2010</year>
<volume>107</volume>
<fpage>8452</fpage>
<lpage>8456</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1000496107</pub-id>
<pub-id pub-id-type="pmid">20404184</pub-id>
</element-citation>
</ref>
<ref id="B60-biomolecules-10-00848">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stevens</surname>
<given-names>F.L.</given-names>
</name>
<name>
<surname>Hurley</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Taber</surname>
<given-names>K.H.</given-names>
</name>
</person-group>
<article-title>Anterior cingulate cortex: Unique role in cognition and emotion</article-title>
<source/>J. NeuroPsychiatry Clin. Neurosci.
          <year>2011</year>
<volume>23</volume>
<fpage>121</fpage>
<lpage>125</lpage>
<pub-id pub-id-type="doi">10.1176/jnp.23.2.jnp121</pub-id>
<pub-id pub-id-type="pmid">21677237</pub-id>
</element-citation>
</ref>
<ref id="B61-biomolecules-10-00848">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cho</surname>
<given-names>Y.T.</given-names>
</name>
<name>
<surname>Ernst</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fudge</surname>
<given-names>J.L.</given-names>
</name>
</person-group>
<article-title>Cortico-amygdala-striatal circuits are organized as hierarchical subsystems through the primate amygdala</article-title>
<source/>J. Neurosci.
          <year>2013</year>
<volume>33</volume>
<fpage>14017</fpage>
<lpage>14030</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0170-13.2013</pub-id>
<pub-id pub-id-type="pmid">23986238</pub-id>
</element-citation>
</ref>
<ref id="B62-biomolecules-10-00848">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anderson</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Bunce</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Barbas</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Prefrontal-hippocampal pathways underlying inhibitory control over memory</article-title>
<source/>Neurobiol. Learn. Memory
          <year>2016</year>
<volume>134</volume>
<fpage>145</fpage>
<lpage>161</lpage>
<pub-id pub-id-type="doi">10.1016/j.nlm.2015.11.008</pub-id>
</element-citation>
</ref>
<ref id="B63-biomolecules-10-00848">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tewari</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jog</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Jog</surname>
<given-names>M.S.</given-names>
</name>
</person-group>
<article-title>The Striatum and Subthalamic Nucleus as Independent and Collaborative Structures in Motor Control</article-title>
<source/>Front. Syst. Neurosci.
          <year>2016</year>
<volume>10</volume>
<fpage>17</fpage>
<pub-id pub-id-type="doi">10.3389/fnsys.2016.00017</pub-id>
<pub-id pub-id-type="pmid">26973474</pub-id>
</element-citation>
</ref>
<ref id="B64-biomolecules-10-00848">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bullitt</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Expression of c-fos-like protein as a marker for neuronal activity following noxious stimulation in the rat</article-title>
<source/>J. Comp. Neurol.
          <year>1990</year>
<volume>296</volume>
<fpage>517</fpage>
<lpage>530</lpage>
<pub-id pub-id-type="doi">10.1002/cne.902960402</pub-id>
<pub-id pub-id-type="pmid">2113539</pub-id>
</element-citation>
</ref>
<ref id="B65-biomolecules-10-00848">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Elzakker</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fevurly</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Breindel</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>R.L.</given-names>
</name>
</person-group>
<article-title>Environmental novelty is associated with a selective increase in Fos expression in the output elements of the hippocampal formation and the perirhinal cortex</article-title>
<source/>Learn. Memory
          <year>2008</year>
<volume>15</volume>
<fpage>899</fpage>
<lpage>908</lpage>
<pub-id pub-id-type="doi">10.1101/lm.1196508</pub-id>
</element-citation>
</ref>
<ref id="B66-biomolecules-10-00848">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montgomery</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Betancur</surname>
<given-names>M.I.</given-names>
</name>
<name>
<surname>Buzsaki</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Behavior-dependent coordination of multiple theta dipoles in the hippocampus</article-title>
<source/>J. Neurosci.
          <year>2009</year>
<volume>29</volume>
<fpage>1381</fpage>
<lpage>1394</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4339-08.2009</pub-id>
<pub-id pub-id-type="pmid">19193885</pub-id>
</element-citation>
</ref>
<ref id="B67-biomolecules-10-00848">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Degroot</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Treit</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Dorsal and ventral hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests</article-title>
<source/>Brain Res.
          <year>2002</year>
<volume>949</volume>
<fpage>60</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-8993(02)02965-7</pub-id>
<pub-id pub-id-type="pmid">12213300</pub-id>
</element-citation>
</ref>
<ref id="B68-biomolecules-10-00848">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaltiel</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hanan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Barbash</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kovalev</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Shoham</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Soreq</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Hippocampal microRNA-132 mediates stress-inducible cognitive deficits through its acetylcholinesterase target</article-title>
<source/>Brain Struct. Funct.
          <year>2013</year>
<volume>218</volume>
<fpage>59</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="doi">10.1007/s00429-011-0376-z</pub-id>
<pub-id pub-id-type="pmid">22246100</pub-id>
</element-citation>
</ref>
<ref id="B69-biomolecules-10-00848">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname>
<given-names>W.Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.L.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hang</surname>
<given-names>C.H.</given-names>
</name>
</person-group>
<article-title>MicroRNA-370-3p inhibits human vascular smooth muscle cell proliferation via targeting KDR/AKT signaling pathway in cerebral aneurysm</article-title>
<source/>Eur. Rev. Med. Pharmacol. Sci.
          <year>2017</year>
<volume>21</volume>
<fpage>1080</fpage>
<lpage>1087</lpage>
<pub-id pub-id-type="pmid">28338184</pub-id>
</element-citation>
</ref>
<ref id="B70-biomolecules-10-00848">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Menger</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Laschke</surname>
<given-names>M.W.</given-names>
</name>
</person-group>
<article-title>miR-370 inhibits the angiogenic activity of endothelial cells by targeting smoothened (SMO) and bone morphogenetic protein (BMP)-2</article-title>
<source/>FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol.
          <year>2019</year>
<volume>33</volume>
<fpage>7213</fpage>
<lpage>7224</lpage>
<pub-id pub-id-type="doi">10.1096/fj.201802085RR</pub-id>
</element-citation>
</ref>
<ref id="B71-biomolecules-10-00848">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wa</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>miR-204-5p Represses Bone Metastasis via Inactivating NF-kappaB Signaling in Prostate Cancer</article-title>
<source/>Mol. Ther. Nucleic Acids
          <year>2019</year>
<volume>18</volume>
<fpage>567</fpage>
<lpage>579</lpage>
<pub-id pub-id-type="doi">10.1016/j.omtn.2019.09.008</pub-id>
<pub-id pub-id-type="pmid">31678733</pub-id>
</element-citation>
</ref>
<ref id="B72-biomolecules-10-00848">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hebert</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>De Strooper</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Alterations of the microRNA network cause neurodegenerative disease</article-title>
<source/>Trends Neurosci.
          <year>2009</year>
<volume>32</volume>
<fpage>199</fpage>
<lpage>206</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2008.12.003</pub-id>
<pub-id pub-id-type="pmid">19268374</pub-id>
</element-citation>
</ref>
<ref id="B73-biomolecules-10-00848">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sticht</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>De La Torre</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Parveen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gretz</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>miRWalk: An online resource for prediction of microRNA binding sites</article-title>
<source/>PLoS ONE
          <year>2018</year>
<volume>13</volume>
<elocation-id>e0206239</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0206239</pub-id>
<pub-id pub-id-type="pmid">30335862</pub-id>
</element-citation>
</ref>
<ref id="B74-biomolecules-10-00848">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furey</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Pietrini</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Haxby</surname>
<given-names>J.V.</given-names>
</name>
</person-group>
<article-title>Cholinergic enhancement and increased selectivity of perceptual processing during working memory</article-title>
<source/>Science
          <year>2000</year>
<volume>290</volume>
<fpage>2315</fpage>
<lpage>2319</lpage>
<pub-id pub-id-type="doi">10.1126/science.290.5500.2315</pub-id>
<pub-id pub-id-type="pmid">11125148</pub-id>
</element-citation>
</ref>
<ref id="B75-biomolecules-10-00848">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pittenger</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kandel</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>A genetic switch for long-term memory</article-title>
<source/>C. R. Acad. Sci. III
          <year>1998</year>
<volume>321</volume>
<fpage>91</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="doi">10.1016/S0764-4469(97)89807-1</pub-id>
<pub-id pub-id-type="pmid">9759326</pub-id>
</element-citation>
</ref>
<ref id="B76-biomolecules-10-00848">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farchi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Shoham</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hochner</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Soreq</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Impaired hippocampal plasticity and errors in cognitive performance in mice with maladaptive neuronal splice site selection</article-title>
<source/>Eur. J. Neurochem.
          <year>2007</year>
<volume>25</volume>
<fpage>87</fpage>
<lpage>98</lpage>
</element-citation>
</ref>
<ref id="B77-biomolecules-10-00848">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schoch</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Deak</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Konigstorfer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mozhayeva</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sara</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sudhof</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Kavalali</surname>
<given-names>E.T.</given-names>
</name>
</person-group>
<article-title>SNARE function analyzed in synaptobrevin/VAMP knockout mice</article-title>
<source/>Science
          <year>2001</year>
<volume>294</volume>
<fpage>1117</fpage>
<lpage>1122</lpage>
<pub-id pub-id-type="doi">10.1126/science.1064335</pub-id>
<pub-id pub-id-type="pmid">11691998</pub-id>
</element-citation>
</ref>
<ref id="B78-biomolecules-10-00848">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Ferrari</surname>
<given-names>G.V.</given-names>
</name>
<name>
<surname>Inestrosa</surname>
<given-names>N.C.</given-names>
</name>
</person-group>
<article-title>Wnt signaling function in Alzheimer’s disease</article-title>
<source/>Brain Res. Brain Res. Rev.
          <year>2000</year>
<volume>33</volume>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1016/S0165-0173(00)00021-7</pub-id>
<pub-id pub-id-type="pmid">10967351</pub-id>
</element-citation>
</ref>
<ref id="B79-biomolecules-10-00848">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simantov</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Multiple molecular and neuropharmacological effects of MDMA (Ecstasy)</article-title>
<source/>Life Sci.
          <year>2004</year>
<volume>74</volume>
<fpage>803</fpage>
<lpage>814</lpage>
<pub-id pub-id-type="doi">10.1016/j.lfs.2003.08.002</pub-id>
<pub-id pub-id-type="pmid">14659969</pub-id>
</element-citation>
</ref>
<ref id="B80-biomolecules-10-00848">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Conti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Minelli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Melone</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>GABA transporters in the mammalian cerebral cortex: Localization, development and pathological implications</article-title>
<source/>Brain Res. Brain Res. Rev.
          <year>2004</year>
<volume>45</volume>
<fpage>196</fpage>
<lpage>212</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainresrev.2004.03.003</pub-id>
<pub-id pub-id-type="pmid">15210304</pub-id>
</element-citation>
</ref>
<ref id="B81-biomolecules-10-00848">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garty</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lindzen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fuzesi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Aizman</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Goldshleger</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Asher</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Karlish</surname>
<given-names>S.J.</given-names>
</name>
</person-group>
<article-title>A specific functional interaction between CHIF and Na,K-ATPase: Role of FXYD proteins in the cellular regulation of the pump</article-title>
<source/>Ann. N. Y. Acad. Sci.
          <year>2003</year>
<volume>986</volume>
<fpage>395</fpage>
<lpage>400</lpage>
<pub-id pub-id-type="doi">10.1111/j.1749-6632.2003.tb07220.x</pub-id>
<pub-id pub-id-type="pmid">12763856</pub-id>
</element-citation>
</ref>
<ref id="B82-biomolecules-10-00848">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pearl</surname>
<given-names>P.L.</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>K.M.</given-names>
</name>
</person-group>
<article-title>Clinical aspects of the disorders of GABA metabolism in children</article-title>
<source/>Curr. Opin. Neurol.
          <year>2004</year>
<volume>17</volume>
<fpage>107</fpage>
<lpage>113</lpage>
<pub-id pub-id-type="doi">10.1097/00019052-200404000-00005</pub-id>
<pub-id pub-id-type="pmid">15021235</pub-id>
</element-citation>
</ref>
<ref id="B83-biomolecules-10-00848">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Contractor</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Heinemann</surname>
<given-names>S.F.</given-names>
</name>
</person-group>
<article-title>Glutamate receptor trafficking in synaptic plasticity</article-title>
<source/>Sci. STKE
          <year>2002</year>
<volume>2002</volume>
<fpage>RE14</fpage>
<pub-id pub-id-type="doi">10.1126/stke.2002.156.re14</pub-id>
<pub-id pub-id-type="pmid">12407224</pub-id>
</element-citation>
</ref>
<ref id="B84-biomolecules-10-00848">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>Y.Y.</given-names>
</name>
<name>
<surname>Farchi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ju</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hochner</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Soreq</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Excessive expression of acetylcholinesterase impairs glutamatergic synaptogenesis in hippocampal neurons</article-title>
<source/>J. Neurosci.
          <year>2004</year>
<volume>24</volume>
<fpage>8950</fpage>
<lpage>8960</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2106-04.2004</pub-id>
<pub-id pub-id-type="pmid">15483114</pub-id>
</element-citation>
</ref>
<ref id="B85-biomolecules-10-00848">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farchi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ofek</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Podoly</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>Y.-Y.</given-names>
</name>
<name>
<surname>Diamant</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Livnah</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Hochner</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>W.-Y.</given-names>
</name>
<name>
<surname>Soreq</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Peripheral site acetylcholinesterase blockade induces RACK-1 associated neuronal modeling. in press</article-title>
<source/>Neurodegener. Dis.
          <year>2007</year>
<volume>4</volume>
<fpage>171</fpage>
<lpage>184</lpage>
<pub-id pub-id-type="doi">10.1159/000101842</pub-id>
<pub-id pub-id-type="pmid">17596712</pub-id>
</element-citation>
</ref>
<ref id="B86-biomolecules-10-00848">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niwa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kanda</surname>
<given-names>G.N.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sunagawa</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Ukai-Tadenuma</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fujishima</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Masumoto</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Nagano</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Muscarinic Acetylcholine Receptors Chrm1 and Chrm3 Are Essential for REM Sleep</article-title>
<source/>Cell Rep.
          <year>2018</year>
<volume>24</volume>
<fpage>2231</fpage>
<lpage>2247</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2018.07.082</pub-id>
<pub-id pub-id-type="pmid">30157420</pub-id>
</element-citation>
</ref>
<ref id="B87-biomolecules-10-00848">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarter</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hasselmo</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Bruno</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Givens</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Unraveling the attentional functions of cortical cholinergic inputs: Interactions between signal-driven and cognitive modulation of signal detection</article-title>
<source/>Brain Res. Brain Res. Rev.
          <year>2005</year>
<volume>48</volume>
<fpage>98</fpage>
<lpage>111</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainresrev.2004.08.006</pub-id>
<pub-id pub-id-type="pmid">15708630</pub-id>
</element-citation>
</ref>
<ref id="B88-biomolecules-10-00848">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>Z.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of genetic variants of GRIN2B with autism</article-title>
<source/>Sci. Rep.
          <year>2015</year>
<volume>5</volume>
<fpage>8296</fpage>
<pub-id pub-id-type="doi">10.1038/srep08296</pub-id>
<pub-id pub-id-type="pmid">25656819</pub-id>
</element-citation>
</ref>
<ref id="B89-biomolecules-10-00848">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buxbaum</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Chaste</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nygren</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Goldsmith</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Reichert</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Anckarsater</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rastam</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Silverman</surname>
<given-names>J.M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly</article-title>
<source/>Am. J. Med. Genet. Part B NeuroPsychiatry Genet. Off. Publ. Int. Soc. Psychiatry Genet.
          <year>2007</year>
<volume>144B</volume>
<fpage>484</fpage>
<lpage>491</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.30493</pub-id>
</element-citation>
</ref>
<ref id="B90-biomolecules-10-00848">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leblond</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Nava</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Polge</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gauthier</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huguet</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lumbroso</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Giuliano</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Stordeur</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Depienne</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mouzat</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A gradient of severity in cognitive impairments</article-title>
<source/>PLoS Genet.
          <year>2014</year>
<volume>10</volume>
<elocation-id>e1004580</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1004580</pub-id>
<pub-id pub-id-type="pmid">25188300</pub-id>
</element-citation>
</ref>
<ref id="B91-biomolecules-10-00848">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amal</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Barak</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bhat</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Joughin</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wishnok</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tannenbaum</surname>
<given-names>S.R.</given-names>
</name>
</person-group>
<article-title>Shank3 mutation in a mouse model of autism leads to changes in the S-nitroso-proteome and affects key proteins involved in vesicle release and synaptic function</article-title>
<source/>Mol. Psychiatry
          <year>2018</year>
<pub-id pub-id-type="doi">10.1038/s41380-018-0113-6</pub-id>
</element-citation>
</ref>
<ref id="B92-biomolecules-10-00848">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mongeau</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>D.J.</given-names>
</name>
</person-group>
<article-title>Neural correlates of competing fear behaviors evoked by an innately aversive stimulus</article-title>
<source/>J. Neurosci.
          <year>2003</year>
<volume>23</volume>
<fpage>3855</fpage>
<lpage>3868</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-09-03855.2003</pub-id>
<pub-id pub-id-type="pmid">12736356</pub-id>
</element-citation>
</ref>
<ref id="B93-biomolecules-10-00848">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neveu</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Moya</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>In the mouse, the corticoid stress response depends on lateralization</article-title>
<source/>Brain Res.
          <year>1997</year>
<volume>749</volume>
<fpage>344</fpage>
<lpage>346</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-8993(96)01416-3</pub-id>
<pub-id pub-id-type="pmid">9138736</pub-id>
</element-citation>
</ref>
<ref id="B94-biomolecules-10-00848">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lobentanzer</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hanin</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Soreq</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Integrative Transcriptomics Reveals Sexually Dimorphic Control of the Cholinergic/Neurokine Interface in Schizophrenia and Bipolar Disorder</article-title>
<source/>Cell Rep.
          <year>2019</year>
<volume>29</volume>
<fpage>764</fpage>
<lpage>777</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2019.09.017</pub-id>
<pub-id pub-id-type="pmid">31618642</pub-id>
</element-citation>
</ref>
<ref id="B95-biomolecules-10-00848">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dudai</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yayon</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Lerner</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Tasaka</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Deitcher</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Niederhoffer</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Mizrahi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Soreq</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>London</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Functional characterization of cortical ChAT/VIP interneurons and their effect on the circuit in vivo</article-title>
<source/>PLoS Biol.
          <year>2020</year>
<comment>in press</comment>
</element-citation>
</ref>
<ref id="B96-biomolecules-10-00848">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Birikh</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Sklan</surname>
<given-names>E.H.</given-names>
</name>
<name>
<surname>Shoham</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Soreq</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Interaction of “readthrough” acetylcholinesterase with RACK1 and PKCbeta II correlates with intensified fear-induced conflict behavior</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2003</year>
<volume>100</volume>
<fpage>283</fpage>
<lpage>288</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0135647100</pub-id>
<pub-id pub-id-type="pmid">12509514</pub-id>
</element-citation>
</ref>
<ref id="B97-biomolecules-10-00848">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nijholt</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Farchi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kye</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sklan</surname>
<given-names>E.H.</given-names>
</name>
<name>
<surname>Shoham</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Verbeure</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Owen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hochner</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Spiess</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Soreq</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Stress-induced alternative splicing of acetylcholinesterase results in enhanced fear memory and long-term potentiation</article-title>
<source/>Mol. Psychiatry
          <year>2004</year>
<volume>9</volume>
<fpage>174</fpage>
<lpage>183</lpage>
<pub-id pub-id-type="doi">10.1038/sj.mp.4001446</pub-id>
<pub-id pub-id-type="pmid">14581933</pub-id>
</element-citation>
</ref>
<ref id="B98-biomolecules-10-00848">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Graybiel</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Canales</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Capper-Loup</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Levodopa-induced dyskinesias and dopamine-dependent stereotypies: A new hypothesis</article-title>
<source/>Trends Neurosci.
          <year>2000</year>
<volume>23</volume>
<fpage>S71</fpage>
<lpage>S77</lpage>
<pub-id pub-id-type="doi">10.1016/S1471-1931(00)00027-6</pub-id>
<pub-id pub-id-type="pmid">11052223</pub-id>
</element-citation>
</ref>
<ref id="B99-biomolecules-10-00848">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeffries</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Schooler</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Schoenbach</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Herscovitch</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chase</surname>
<given-names>T.N.</given-names>
</name>
<name>
<surname>Braun</surname>
<given-names>A.R.</given-names>
</name>
</person-group>
<article-title>The functional neuroanatomy of Tourette’s syndrome: An FDG PET study III: Functional coupling of regional cerebral metabolic rates</article-title>
<source/>Neuropsychopharmacology
          <year>2002</year>
<volume>27</volume>
<fpage>92</fpage>
<lpage>104</lpage>
<pub-id pub-id-type="doi">10.1016/S0893-133X(01)00428-6</pub-id>
<pub-id pub-id-type="pmid">12062910</pub-id>
</element-citation>
</ref>
<ref id="B100-biomolecules-10-00848">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chappell</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Leckman</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Goodman</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Bissette</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pauls</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Riddle</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Scahill</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>McDougle</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Elevated cerebrospinal fluid corticotropin-releasing factor in Tourette’s syndrome: Comparison to obsessive compulsive disorder and normal controls</article-title>
<source/>Biol. Psychiatry
          <year>1996</year>
<volume>39</volume>
<fpage>776</fpage>
<lpage>783</lpage>
<pub-id pub-id-type="doi">10.1016/0006-3223(95)00221-9</pub-id>
<pub-id pub-id-type="pmid">8731518</pub-id>
</element-citation>
</ref>
<ref id="B101-biomolecules-10-00848">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moriarty</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Schmitz</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Trimble</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Ell</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>M.M.</given-names>
</name>
</person-group>
<article-title>Brain perfusion abnormalities in Gilles de la Tourette’s syndrome</article-title>
<source/>Br. J. Psychiatry
          <year>1995</year>
<volume>167</volume>
<fpage>249</fpage>
<lpage>254</lpage>
<pub-id pub-id-type="doi">10.1192/bjp.167.2.249</pub-id>
<pub-id pub-id-type="pmid">7582678</pub-id>
</element-citation>
</ref>
<ref id="B102-biomolecules-10-00848">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peterson</surname>
<given-names>B.S.</given-names>
</name>
<name>
<surname>Skudlarski</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>A.W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gatenby</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Lacadie</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Leckman</surname>
<given-names>J.F.</given-names>
</name>
<name>
<surname>Gore</surname>
<given-names>J.C.</given-names>
</name>
</person-group>
<article-title>A functional magnetic resonance imaging study of tic suppression in Tourette syndrome</article-title>
<source/>Arch. Gen. Psychiatry
          <year>1998</year>
<volume>55</volume>
<fpage>326</fpage>
<lpage>333</lpage>
<pub-id pub-id-type="doi">10.1001/archpsyc.55.4.326</pub-id>
<pub-id pub-id-type="pmid">9554428</pub-id>
</element-citation>
</ref>
<ref id="B103-biomolecules-10-00848">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cabib</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Giardino</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Calza</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zanni</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mele</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Puglisi-Allegra</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Stress promotes major changes in dopamine receptor densities within the mesoaccumbens and nigrostriatal systems</article-title>
<source/>Neuroscience
          <year>1998</year>
<volume>84</volume>
<fpage>193</fpage>
<lpage>200</lpage>
<pub-id pub-id-type="doi">10.1016/S0306-4522(97)00468-5</pub-id>
<pub-id pub-id-type="pmid">9522373</pub-id>
</element-citation>
</ref>
<ref id="B104-biomolecules-10-00848">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bracha</surname>
<given-names>H.S.</given-names>
</name>
</person-group>
<article-title>Asymmetric rotational (circling) behavior, a dopamine-related asymmetry: Preliminary findings in unmedicated and never-medicated schizophrenic patients</article-title>
<source/>Biol. Psychiatry
          <year>1987</year>
<volume>22</volume>
<fpage>995</fpage>
<lpage>1003</lpage>
<pub-id pub-id-type="doi">10.1016/0006-3223(87)90009-6</pub-id>
<pub-id pub-id-type="pmid">3607140</pub-id>
</element-citation>
</ref>
<ref id="B105-biomolecules-10-00848">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sklan</surname>
<given-names>E.H.</given-names>
</name>
<name>
<surname>Lowenthal</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Korner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ritov</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Landers</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Rankinen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bouchard</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Leon</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Rice</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>D.C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Acetylcholinesterase/paraoxonase genotype and expression predict anxiety scores in Health, Risk Factors, Exercise Training, and Genetics study</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2004</year>
<volume>101</volume>
<fpage>5512</fpage>
<lpage>5517</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0307659101</pub-id>
<pub-id pub-id-type="pmid">15060281</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="biomolecules-10-00848-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>TgR mice show SB profiles. (<bold>A</bold>) Forced swim test. Shown are wall swim (number of swims around the circumference of the circular pool), line/crossing swim (number of episodes in which the mouse made a straight-line path instead of adhering to the wall), body axis circling (lateral circling in the water around the body axis) and asymmetry % (index of asymmetry in direction of swimming; 0 = perfect symmetry, 50% = complete asymmetry). Sample sizes: FVB/N (<italic>n</italic> = 10), TgR (<italic>n</italic> = 14). (<bold>B</bold>–<bold>E</bold>) Open field tests. Shown are locomotion time, episodes, rearing events and the index of asymmetry. (<bold>F</bold>,<bold>G</bold>) Circadian light: dark rhythm and body temperatures in TgR and FVB/N mice. Sample sizes: FVB/N (<italic>n</italic> = 8), TgR (<italic>n</italic> = 6). Asterisks represent significant ANOVA: * 1, * 2, * 3, in the first, second, and third quarters respectively.</p>
</caption>
<graphic xlink:href="biomolecules-10-00848-g001"></graphic>
</fig>
<fig id="biomolecules-10-00848-f002" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<p>Pilocarpine suppresses the motor hyperactivity but not the locomotor asymmetry component of SB. Shown are the effects on motor activity in the open field. Pilocarpine, a muscarinic agonist, at a dose of 25 mg/kg, suppressed motor activity without affecting motor asymmetry. * 1 marks a significant transgene effect. * 2 marks a significant drug effect.</p>
</caption>
<graphic xlink:href="biomolecules-10-00848-g002"></graphic>
</fig>
<fig id="biomolecules-10-00848-f003" orientation="portrait" position="float">
<label>Figure 3</label>
<caption>
<p>(<bold>A</bold>) Simplified structure of the human ACHE gene with its synaptic (AChE-S) and “readthrough” (AChE-R) mRNA 3′ alternative splicing products. (<bold>B</bold>,<bold>C</bold>). Quantitative PCR shows selective increases of the stress-induced AChE-R variant in the cholinoceptive hippocampi of TgR mice, and more modest increases of both AChE-S and AChE-R in the cholinergic prefrontal cortex. Results were normalized to RPL19. (<bold>D</bold>–<bold>F</bold>). AChE-R overexpression in matrix cells positive for the common AChE domain, but not in patches. No hAChE-R labeling appeared in cholinergic nuclei with intense choline-acetyltransferase (ChAT) staining in the medial septum (MS) (<bold>G</bold>), diagonal band (DB) (<bold>H</bold>), and the prepontine tegmental nucleus (PPTG) (<bold>I</bold>). hAChE-R labeling co-appeared in cholinergic nuclei expressing ChAT, with moderate to weak staining, e.g., in the nucleus basalis magnocellularis (NBM) (<bold>J</bold>), striatum (ST) (<bold>K</bold>) and spinal cord (ventral horn) (<bold>L</bold>). Red = ChAT, Green = hAChE-R, Yellow–Orange = co-localization of ChAT and AChE-R.</p>
</caption>
<graphic xlink:href="biomolecules-10-00848-g003"></graphic>
</fig>
<fig id="biomolecules-10-00848-f004" orientation="portrait" position="float">
<label>Figure 4</label>
<caption>
<p>AChE-R shows hierarchical distribution in brain regions controlling motor behavior. (<bold>A</bold>) In FVB/N mice, subsets of CA1 neurons displayed higher than background expression of mouse AChE-R mRNA. (<bold>B</bold>) Neuronal activation (c-fos) patterns show inversed association to AChE-R. In the CA1 region of TgR mice, similar neuronal subsets expressed higher than background levels of the human AChE-R (hAChE-R) protein. (<bold>C</bold>) Using similar procedures, TgR mice presented lower basal level of neuronal activation reflected as c-fos staining in the dorsolateral striatum (LST), medial striatum (MST), anterior cingulate cortex (AC), lateral septum (LS) but not in hippocampal sub-regions CA1-2, CA3, and dentate gyrus (DG).</p>
</caption>
<graphic xlink:href="biomolecules-10-00848-g004"></graphic>
</fig>
<fig id="biomolecules-10-00848-f005" orientation="portrait" position="float">
<label>Figure 5</label>
<caption>
<p><bold>A</bold>. DE miRNAs in the TgR Hippocampus. Enriched DE miRNAs out of global miRNAs in the TgR hippocampus (minimal average expression of 300 normalized counts). Eight miRNAs targeting at least 5 cholinergic genes each and which are also known to be expressed in humans were DE in the TgR hippocampus, out of a total of 36 DE miRNAs. <bold>B</bold>. Network analysis for down- and up-regulated DE cholinergic-targeting miRNAs in the TgR hippocampus. Analysis was done using miRwalk 3.0 using maximum binding <italic>p</italic>-value of 1 and filter to 3’UTR binding and using miRDB database [<xref ref-type="bibr" rid="B73-biomolecules-10-00848">73</xref>].</p>
</caption>
<graphic xlink:href="biomolecules-10-00848-g005"></graphic>
</fig>
<fig id="biomolecules-10-00848-f006" orientation="portrait" position="float">
<label>Figure 6</label>
<caption>
<p>Microarray-validated individual diversity in PFC’s cholinergic-related transcripts compared to the CP. Shown are variabilities between the CP and the PFC in FVB/N mice and the TgR strain. Higher individual variability can be seen in the expression profiles between the PFC and the CP, especially in the SB-prone TgR strain.</p>
</caption>
<graphic xlink:href="biomolecules-10-00848-g006"></graphic>
</fig>
<fig id="biomolecules-10-00848-f007" orientation="portrait" position="float">
<label>Figure 7</label>
<caption>
<p>Glutamatergic transcripts are conspicuously changed in the TgR PFC. (<bold>A</bold>) Log10 Scatter plots demonstrating greater differences between microarray pools of 4 TgR mice PFCs (R1 R2) as compared with pools of 4 FVB/N mice PFCs (C1 C2), and yet greater differences between cross pools (R1 C2, R2 C1, R1 C1, R2 C2). Gray dots depict genes the expression level of which was unaltered between the two tests; black dots depict genes with log ratio higher than 1. (<bold>B</bold>) GOC pathways terms modified in TgR mice relative to parent strain mice. Terms for the biological process and molecular function are shown at the top and bottom, respectively. The lines indicate the hierarchical relationship between the terms. Values indicate the probability to observe the given number of changed transcripts within a term by chance. PFC = prefrontal cortex; GOC = gene ontology categories; pr = process; comm. = communication; act = activity.</p>
</caption>
<graphic xlink:href="biomolecules-10-00848-g007"></graphic>
</fig>
<fig id="biomolecules-10-00848-f008" orientation="portrait" position="float">
<label>Figure 8</label>
<caption>
<p>qPCR-validated change in cholinergic signaling related genes. Most changes between FVB/N mice and the TgR strain occur in the hippocampus. Different expression profiles can be observed between the PFC and hippocampus.</p>
</caption>
<graphic xlink:href="biomolecules-10-00848-g008"></graphic>
</fig>
<table-wrap id="biomolecules-10-00848-t001" orientation="portrait" position="float">
<object-id pub-id-type="pii">biomolecules-10-00848-t001_Table 1</object-id>
<label>Table 1</label>
<caption>
<p>Primer pairs for the tested transcripts are listed below.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Gene</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Forward Primer Sequence</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Reverse Primer Sequence</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Shank3</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CCGGACCTGCAACAAACGA </td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">GCGCGTCTTGAAGGCTATGAT </td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Pten</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">TGGATTCGACTTAGACTTGACCT </td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">GCGGTGTCATAATGTCTCTCAG </td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CHRM3</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CCTCGCCTTTGTTTCCCAAC </td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">TTGAGGAGAAATTCCCAGAGGT </td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CHRM5</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CCTCTACACGACCTACATCCTC </td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">GTATGTCAGTGGTCTTGTGATGG </td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CHRNA7</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CACATTCCACACCAACGTCTT </td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">AAAAGGGAACCAGCGTACATC </td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CNR1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">GTGTTCCACCGCAAAGATAGT </td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">GCCTGTGAATGGATATGTACCTG </td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Grin2b</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CAGCAAAGCTCGTTCCCAAAA</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">GTCAGTCTCGTTCATGGCTAC </td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Grin2a</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">ACGTGACAGAACGCGAACTT </td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">TCAGTGCGGTTCATCAATAACG </td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Grin1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">AGAGCCCGACCCTAAAAAGAA </td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CCCTCCTCCCTCTCAATAGC </td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">DLG3</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">AACAGATCGGTGTGATCCCTA </td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CTGTCCTGGCATGGAACTTCA </td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">AChE-S</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CTGAACCTGAAGCCCTTAGAG</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CCGCCTCGTCCAGAGTAT</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">AChE-R</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CTGAACCTGAAGCCCTTAGAG</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">GGGGAGGTGGAGAAGAGAG</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Beta-actin</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">CCACACCCGCCACCAGTT</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">TACAGCCCGGGGAGCAT</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">RPL-19</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">GATTGACCGCCATATGTATCAC</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">GTCAGCCAGGAGCTTCTTG</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="biomolecules-10-00848-t002" orientation="portrait" position="float">
<object-id pub-id-type="pii">biomolecules-10-00848-t002_Table 2</object-id>
<label>Table 2</label>
<caption>
<p>The behavioral paradigm. Behavioral tests comparing naive FVB/N, TgR-L and TgR-H mice.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Test Paradigm</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Variable</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">F Value</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Degrees of Freedom</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle"><italic>p</italic> Value</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Significant Post Hoc N.K. Tests, <italic>p</italic> &lt; 0.05</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="10" style="border-bottom:solid thin" valign="middle">1. Open field</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Age 17 weeks</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Locomotion time</td>
<td align="center" colspan="1" rowspan="1" valign="middle">16.5</td>
<td align="center" colspan="1" rowspan="1" valign="middle">(2.16)</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.0001</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TgR-H &gt; TgR-L, FVB/N</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Locomotion episodes</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">N.S.</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Locomotor asymmetry</td>
<td align="center" colspan="1" rowspan="1" valign="middle">31.7</td>
<td align="center" colspan="1" rowspan="1" valign="middle">(2.16)</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.0001</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TgR-H &gt; TgR-L, FVB/N</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Rearing</td>
<td align="center" colspan="1" rowspan="1" valign="middle">29.6</td>
<td align="center" colspan="1" rowspan="1" valign="middle">(2.16)</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.005</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TgR-H &lt; TgR-L, FVB/N</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Age 30 weeks</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Locomotion time</td>
<td align="center" colspan="1" rowspan="1" valign="middle">19.9</td>
<td align="center" colspan="1" rowspan="1" valign="middle">(2.32)</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.0001</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TgR-H &gt; TgR-L, FVB/N</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Locomotion episodes</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">N.S.</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Locomotor asymmetry</td>
<td align="center" colspan="1" rowspan="1" valign="middle">20.7</td>
<td align="center" colspan="1" rowspan="1" valign="middle">(2.32)</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.0001</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TgR-H &gt; TgR-L, FVB/N</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Rearing</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">7.8</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">(2.32)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.005</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">TgR-H &lt; TgR-L, FVB/N</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="4" style="border-bottom:solid thin" valign="middle">2. Forced swim</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Swims along wall </td>
<td align="center" colspan="1" rowspan="1" valign="middle">18.6</td>
<td align="center" colspan="1" rowspan="1" valign="middle">(2.29)</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.0001</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TgR-H &gt; TgR-L, FVB/N</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Swims across pool</td>
<td align="center" colspan="1" rowspan="1" valign="middle">10.5</td>
<td align="center" colspan="1" rowspan="1" valign="middle">(2.29)</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.0005</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TgR-H &lt; TgR-L, FVB/N</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Body-wise circling</td>
<td align="center" colspan="1" rowspan="1" valign="middle">9.2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">(2.29)</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.0005</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TgR-H &gt; TgR-L, FVB/N</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">% Asymmetry</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">21.1</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">(2.29)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.0001</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">TgR-H &gt; TgR-L, FVB/N</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="middle">3. Serial choice maze </td>
<td align="center" colspan="1" rowspan="1" valign="middle">Right/left choice errors</td>
<td align="center" colspan="1" rowspan="1" valign="middle">19.1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">(2.47)</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.0001</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TgR-H &gt; TgR-L&gt;FVB/N</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Retrace errors</td>
<td align="center" colspan="1" rowspan="1" valign="middle">14.0</td>
<td align="center" colspan="1" rowspan="1" valign="middle">(2.47)</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.001</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TgR-H &gt; FVB/N</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Errorless runs</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">11.0</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">(2.47)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.0001</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">TgR-H &lt; FVB/N</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Comparisons were made using one-way analysis of variance (ANOVA). Entries display ANOVA test results and post-hoc Neumann–Keuls (N.K.) comparisons. Abbreviations: N.S. = main effect of transgene was not significant. The &gt; sign denotes a value being significantly larger than the next mentioned value, the sign &lt; denotes ‘smaller than the next value’.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="biomolecules-10-00848-t003" orientation="portrait" position="float">
<object-id pub-id-type="pii">biomolecules-10-00848-t003_Table 3</object-id>
<label>Table 3</label>
<caption>
<p>Circadian rhythms in naive FVB/N, TgR-L and TgR-H mice.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Biological Activity</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Circadian Time Interval</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">F Value</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Degrees of Freedom</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle"><italic>p</italic> Value</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Significant Post Hoc N.K. Tests, <italic>p</italic> &lt; 0.05</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="4" style="border-bottom:solid thin" valign="middle">1. Locomotion</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Light phase, 1st half</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">N.S.</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Light phase, 2nd half</td>
<td align="center" colspan="1" rowspan="1" valign="middle">11.2</td>
<td align="center" colspan="1" rowspan="1" valign="middle">(2.21)</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.0005</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TgR-H &gt; TgR-L, FVB/N</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Dark phase, 1st half</td>
<td align="center" colspan="1" rowspan="1" valign="middle">11.8</td>
<td align="center" colspan="1" rowspan="1" valign="middle">(2.21)</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.0005</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TgR-H &gt; TgR-L, FVB/N</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Dark phase, 2nd half</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">42</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">(2.21)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.0001</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">FVB/N &gt; TgR-H, TgR-L</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="4" style="border-bottom:solid thin" valign="middle">2. Temperature</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Light phase, 1st half</td>
<td align="center" colspan="1" rowspan="1" valign="middle">4.3</td>
<td align="center" colspan="1" rowspan="1" valign="middle">(2.21)</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.03</td>
<td align="center" colspan="1" rowspan="1" valign="middle">FVB/N &gt; TgR-H, TgR-L</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Light phase, 2nd half</td>
<td align="center" colspan="1" rowspan="1" valign="middle">7.5</td>
<td align="center" colspan="1" rowspan="1" valign="middle">(2.21)</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.0001</td>
<td align="center" colspan="1" rowspan="1" valign="middle">FVB/N &lt; TgR-H, TgR-L</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Dark phase, 1st half</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">N.S.</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Dark phase, 2nd half</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">38</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">(2.21)</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.0005</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">FVB/N &gt; TgR-H, TgR-L</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="5" style="border-bottom:solid thin" valign="middle">3. Circadian correlation: locomotion vs. temperature</td>
<td align="center" colspan="1" rowspan="1" valign="middle">Over the entire 24 h cycle</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">N.S.</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Light phase, 1st half</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">N.S.</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Light phase, 2nd half</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" valign="middle">N.S.</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Dark phase, 1st half</td>
<td align="center" colspan="1" rowspan="1" valign="middle">9.8</td>
<td align="center" colspan="1" rowspan="1" valign="middle">(2.21)</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.001</td>
<td align="center" colspan="1" rowspan="1" valign="middle">FVB/N &lt; TgR-H, TgR-L</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Dark phase, 2nd half</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">N.S.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Comparisons were made using one-way analysis of variance (ANOVA). Entries display ANOVA test results and post-hoc Neumann–Keuls (N.K.) comparisons. Abbreviations: N.S. = main effect of transgene was not significant.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="biomolecules-10-00848-t004" orientation="portrait" position="float">
<object-id pub-id-type="pii">biomolecules-10-00848-t004_Table 4</object-id>
<label>Table 4</label>
<caption>
<p>Neuronal c-fos activation in key structures of the emotional-motor interface.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Brain Region</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">F Value</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle"><italic>p</italic> Value</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Significant Post Hoc N.K. Tests, <italic>p</italic> &lt; 0.05</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Dorsolateral striatum</td>
<td align="center" colspan="1" rowspan="1" valign="middle">3.81</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.036</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TgRL &gt; TgRH, FVB/N</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Medial striatum</td>
<td align="center" colspan="1" rowspan="1" valign="middle">4.47</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.0223</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TgRH &lt; TgRL, FVB/N</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Anterior cingulate cortex</td>
<td align="center" colspan="1" rowspan="1" valign="middle">3.19</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.059</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TgRH &lt; FVB/N</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Lateral septum</td>
<td align="center" colspan="1" rowspan="1" valign="middle">3.0</td>
<td align="center" colspan="1" rowspan="1" valign="middle">0.068</td>
<td align="center" colspan="1" rowspan="1" valign="middle">TgRH &lt; FVB/N</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Hippocampus, CA1</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2.8</td>
<td align="center" colspan="1" rowspan="1" valign="middle">N.S.</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">Hippocampus, CA3</td>
<td align="center" colspan="1" rowspan="1" valign="middle">2.23</td>
<td align="center" colspan="1" rowspan="1" valign="middle">N.S.</td>
<td align="center" colspan="1" rowspan="1" valign="middle">
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">Hippocampus, dentate gyrus</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">0.04</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">N.S.</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>This table summarizes results of ANOVA comparing FVB/N (<italic>n</italic> = 6), TgR-L (<italic>n</italic> = 11) and TgR-H mice (<italic>n</italic> = 10). Entries are F value, F (2.24). Abbreviations: N.S. = main effect or interaction not significant.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>